# EDGAR Filing Document

**Accession Number:** 0000001800
**File Stem:** 0001104659-26-075724
**Filing Date:** 2026-6
**Character Count:** 138082
**Document Hash:** 56920be348b903fe7f3ef1c96aef28bd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-075724.hdr.sgml**: 20260630

**ACCESSION NUMBER**: 0001104659-26-075724

**CONFORMED SUBMISSION TYPE**: 11-K

**PUBLIC DOCUMENT COUNT**: 41

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260618

**DATE AS OF CHANGE**: 20260618

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ABBOTT LABORATORIES
- **CENTRAL INDEX KEY:** 0000001800
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 360698440
- **STATE OF INCORPORATION:** IL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 11-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-02189
- **FILM NUMBER:** 261102585

**BUSINESS ADDRESS:**
- **STREET 1:** 100 ABBOTT PARK ROAD
- **CITY:** ABBOTT PARK
- **STATE:** IL
- **ZIP:** 60064-3500
- **BUSINESS PHONE:** 2246676100

**MAIL ADDRESS:**
- **STREET 1:** 100 ABBOTT PARK ROAD
- **CITY:** ABBOTT PARK
- **STATE:** IL
- **ZIP:** 60064-3500

?xml version='1.0' encoding='ASCII'? ABBOTT LABORATORIES_December 31, 2025

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D. C. 20549**

**FORM 11-K**

**FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS**

**AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

(Mark One)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**☒** **ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

For the fiscal year ended December 31, 2025

**OR**

**☐** **TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Commission File Number 1-2189

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Full title of the plan and the address of the plan, if different from that of the issuer named below:

ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

ABBOTT LABORATORIES

100 Abbott Park Road

Abbott Park, Illinois 60064-6049

------

#### FINANCIAL STATEMENTS AND

#### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

#### ABBOTT LABORATORIES STOCK RETIREMENT PLAN

#### DECEMBER 31, 2025 AND 2024

#### C O N T E N T S

---

| | |
|:---|:---|
|  | **Page** |
| [REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM](#Report1) | 3 |
| FINANCIAL STATEMENTS |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS](#NetAssets1) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS](#ChangeinNetAssets1) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[NOTES TO FINANCIAL STATEMENTS](#NOTEA_916164) | 6 |
| [SUPPLEMENTAL SCHEDULE](#SUPPLEMENTALSCHEDULE_17620) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)](#ScheduleH1) | 16 |

---

#### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Plan Administrator and Plan Participants

Abbott Laboratories Stock Retirement Plan

#### Opinion on the financial statements
We have audited the accompanying statements of net assets available for benefits of Abbott Laboratories Stock Retirement Plan (the "Plan") as of December 31, 2025 and 2024, the related statement of changes in net assets available for benefits for the year ended December 31, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2025 and 2024, and the changes in net assets available for benefits for the year ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.

#### Basis for opinion
These financial statements are the responsibility of the Plan's management. Our responsibility is to express an opinion on the Plan's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

#### Supplemental information
The schedule of assets (held at end of year) as of December 31, 2025 ("supplemental information") has been subjected to audit procedures performed in conjunction with the audit of the Plan's financial statements. The supplemental information is the responsibility of the Plan's management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor's Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.

/s/ GRANT THORNTON LLP

We have served as the Plan's auditor since 2002.

Chicago, Illinois

June 18, 2026

**Abbott Laboratories Stock Retirement Plan**

**STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS**

**December 31, 2025 and 2024**

**(Dollars in thousands)**

------

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Assets |  |  |
| &nbsp;&nbsp;Cash | $— | $1011 |
| &nbsp;&nbsp;Investments, at fair value | 17659748 | 15576603 |
| &nbsp;&nbsp;Employer contributions receivable | 78705 | 43461 |
| &nbsp;&nbsp;Notes receivable from participants | 107491 | 100167 |
| &nbsp;&nbsp;Accrued interest and dividend income | 412 | 4000 |
| &nbsp;&nbsp;Due from brokers | 642109 | 30426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | 18488465 | 15755668 |
| Liabilities |  |  |
| &nbsp;&nbsp;Investments sold short, at fair value | 327342 | 19750 |
| &nbsp;&nbsp;Cash overdraft | 19800 |  |
| &nbsp;&nbsp;Accrued investment expenses | 203 | 208 |
| &nbsp;&nbsp;Due to brokers | 300104 | 10441 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 647449 | 30399 |
| **NET ASSETS AVAILABLE FOR BENEFITS** | $17841016 | $15725269 |

---

The accompanying notes are an integral part of these statements.

**Abbott Laboratories Stock Retirement Plan**

**STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS**

**Year ended December 31, 2025**

**(Dollars in thousands)**

------

---

| | |
|:---|:---|
| Additions |  |
| &nbsp;&nbsp;Contributions |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employer | $291318 |
| &nbsp;&nbsp;&nbsp;&nbsp;Participant | 433176 |
| &nbsp;&nbsp;&nbsp;&nbsp;Rollovers | 37456 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total contributions | 761950 |
| &nbsp;&nbsp;Investment income |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net appreciation in fair value of investments | 2619788 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and dividends | 138283 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 2758071 |
| &nbsp;&nbsp;Interest income on notes receivable from participants | 7184 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total additions | 3527205 |
| Deductions |  |
| &nbsp;&nbsp;Benefits paid to participants | 1411233 |
| &nbsp;&nbsp;Other expenses | 225 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deductions | 1411458 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**NET INCREASE** | 2115747 |
| Net assets available for benefits |  |
| &nbsp;&nbsp;Beginning of year | 15725269 |
| &nbsp;&nbsp;End of year | $17841016 |

---

The accompanying notes are an integral part of this statement.

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS

#### December 31, 2025 and 2024

------

#### NOTE A - DESCRIPTION OF THE PLAN
The following description of the Abbott Laboratories Stock Retirement Plan (the "Plan") provides only general information. Participants should refer to the Plan document for a more complete description of the Plan's provisions.

#### General
The Plan is intended to constitute a profit-sharing plan under Section 401(a) of the Internal Revenue Code of 1986, as amended (the "IRC"), with a cash or deferred arrangement under IRC Section 401(k), and a portion of the Plan is intended to constitute an employee stock ownership plan that meets the applicable requirements of IRC Sections 409 and 4975(e)(7). The Plan is subject to the Employee Retirement Income Security Act of 1974, as amended ("ERISA").

In general, United States employees of Abbott Laboratories ("Abbott") and selected participating subsidiaries and affiliates may, after meeting certain employment requirements, voluntarily participate in the Plan. Beginning March 2017, newly hired employees in certain specified Abbott divisions and business units became eligible to participate in the Plan under a different structure ("Abbott Green" employees).

Alight Solutions serves as the recordkeeper of the Plan. The Northern Trust Company ("Custodian" or "Trustee") serves as the Plan's custodian and trustee.

#### Contributions and Vesting
Contributions to the Plan are paid to the Abbott Laboratories Stock Retirement Trust ("Trust"). The Trust is administered by the Trustee and an investment committee (the "Committee").

Employees are eligible to commence participation in the Plan on any entry date following their date of hire. Eligible employees electing to participate contribute from 2% up to 50% of their eligible earnings, subject to certain limitations. Participants may choose to make their contributions from pretax earnings, after-tax earnings, or both. The Plan also permits Roth 401(k) contributions and has a Roth 401(k) conversion feature. Participants who have attained age 50 before the end of the Plan year and who are making the maximum pretax contributions are eligible to make catch-up contributions. Participants may elect to invest their contributions in any or all of the investment options available under the Plan, except for investment options closed to new contributions.

Employer matching contributions to the Plan are made each payroll period based on the participating employee's eligible earnings, unless the employee has elected to participate as a Freedom 2 Save Participant as described below. The employer matching contribution for the year ended December 31, 2025 was 5% of the participant's eligible earnings if the participant elected to contribute at least 2% of eligible earnings to the Plan.

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE A - DESCRIPTION OF THE PLAN - Continued

#### Contributions and Vesting - Continued
Participants may enroll in the Freedom 2 Save program in the Plan. A Freedom 2 Save participant who makes qualified student loan repayments of at least 2% of eligible earnings may receive a Freedom 2 Save employer contribution of 5% of eligible earnings shortly after the end of the year. An enrolled Freedom 2 Save participant who makes elective deferrals to the Plan will not receive employer matching contributions each payroll period but instead may receive a true-up employer matching contribution shortly after the end of the year for any payroll period for which the participant makes elective deferrals and does not receive a Freedom 2 Save employer contribution. Freedom 2 Save employer contributions and true-up employer matching contributions are only made on behalf of Freedom 2 Save participants who meet program guidelines, and who either are employed or on a qualifying leave of absence at the end of the applicable Plan year or terminate employment due to death or qualifying disability during such Plan year.

Effective June 1, 2024, Plan participants who are not actively participating in the Abbott Laboratories Annuity Retirement Plan may receive an annual employer contribution equal to 3% of the participant's eligible earnings, regardless of whether the participant contributes to the Plan. The 3% annual employer contribution will be made shortly after the end of the Plan year only to the eligible participants who either are employed or on a qualifying leave of absence at the end of the applicable Plan year or who have terminated from employment during that Plan year due to death or qualifying retirement or disability during such Plan year.

Employer contributions are invested according to the participant's investment elections.

Cash dividends on Abbott common shares are (1) paid in cash to the participants or beneficiaries, (2) paid to the Plan and distributed in cash to participants or beneficiaries no later than 90 days after the close of the Plan year for which paid, or (3) paid to the Plan and credited to the accounts in which shares are held, as elected by each participant or beneficiary in accordance with rules established by the administrator.

On January 1, 2013, Abbott separated into two publicly traded companies – Abbott and AbbVie Inc. ("AbbVie"). The separation of Abbott and AbbVie was a tax-free distribution where Abbott shareholders received one share of AbbVie stock for every share of Abbott held as of the close of business on December 12, 2012, the record date for the distribution. Participants who received AbbVie stock through this distribution may continue to hold the stock in their Plan accounts but may not make new contributions or transfer existing contributions or earnings to purchase AbbVie stock in the Plan; however, participants may elect to reinvest their AbbVie dividends in AbbVie stock. If no election is made, AbbVie dividends are invested in the Plan's default investment option.

Participants may direct the Trustee to sell all or a portion of the Abbott and AbbVie common shares held in their accounts and reinvest the proceeds in any of the other available investment options.

Participants are at all times fully vested in their own contributions and earnings thereon. Vesting in employer contributions and earnings thereon is based on the following vesting schedule:

---

| | |
|:---|:---|
| <br>**Service** | **Vesting**<br>**percentage** |
| Less than two years | 0% |
| Two years or more | 100% |

---

#### NOTE A - DESCRIPTION OF THE PLAN - Continued

#### Contributions and Vesting – Continued
A participant becomes 100% vested in his or her employer contributions if, while employed by Abbott, he or she dies or attains age 65. Abbott Green participants who first became participants prior to January 1, 2018 are also fully vested in employer contributions upon qualifying disability.

Non-vested portions of employer contributions and earnings thereon are forfeited as of an employee's termination date. Through December 31, 2024, forfeitures were used to (1) restore any forfeitures of participants who returned to service with Abbott within a

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

given period of time, (2) pay Plan expenses as deemed appropriate by the administrator, and (3) reduce future employer contributions if terminated participants do not return to service within the given period of time. Effective January 1, 2025, forfeitures are used to (1) restore any forfeitures of participants who returned to service with Abbott within a given period of time, and (2) reduce future employer contributions if terminated participants do not return to service within the given period of time.

In 2025, forfeitures reduced Abbott's employer contributions by approximately $6.3 million. Approximately $1.0 million and $1.0 million in forfeitures were available at the end of 2025 and 2024, respectively.

#### Distributions and In-Service Withdrawals
Following retirement, termination or death (or for some participants from merged-in plans, upon disability), participants or their beneficiaries may elect to receive a distribution in installments, in a single lump sum or in a partial lump sum. Participants may elect a direct rollover of their accounts. Also, upon termination, participants may elect to defer distribution to a future date but, after termination of employment, distribution must be made by the 1<sup>st</sup> of April following the year the participant reaches age 73 or, if earlier, the 31<sup>st</sup> of December following the year in which the participant dies. Interest, dividends and other earnings will continue to accrue on such deferred amounts.

Prior to termination, participants are permitted to withdraw their after-tax contributions (after-tax contributions made on or after January 8, 2016 may be withdrawn from the Plan only after being held for two or more years) and rollover contributions (including Roth rollover accounts and merged-in plan rollover accounts) and, after age 59 ½, may also withdraw pretax contributions. Distributions are made in cash or, to the extent contained in the participant's account, a participant may elect distribution of Abbott and AbbVie common shares, and in each case, subject to certain limitations.

#### Notes Receivable from Participants
Participants may convert their vested account balances into one or two loans to themselves. The borrowing may not exceed the lesser of the current market value of the assets allocated to their vested accounts or 50% of all of their Plan accounts up to $50,000, subject to IRC limitations and restrictions. Participants pay interest on such borrowings at the prime rate in effect at the time the participant loan is made. Loans must be repaid within five years unless the loan is used for the purchase of the primary residence of the employee, in which case the repayment period can be extended to a period of fifteen years. Repayment is made through periodic payroll deductions or by sending in payments, but a loan may be repaid in a lump sum at any time. Post-termination loan repayments are permitted. For employees whose account is distributed during the repayment period, the balance of the outstanding loan is netted from their Plan distribution.

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

#### Basis of Accounting
The financial statements have been prepared using the accrual basis of accounting.

#### Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and changes therein, and disclosure of contingent assets and liabilities. Actual results may differ from those estimates.

#### Investment Valuation
The Plan offers a variety of investment options to participants. Certain investment options are structured as separately managed accounts; therefore, the Plan owns the individual investment holdings within the separately managed accounts and reflects them within the investments of the Plan.

The Plan uses the following methods and significant assumptions to estimate the fair value of investments:

Common stock, mutual funds, real estate investment trusts ("REITs") and futures contracts - Valued at the published market price per share or unit multiplied by the number of respective shares or units held.

Collective trust funds and Private 40-Act mutual funds - Valued at the net asset value ("NAV") provided by the administrator of the fund. The NAV is used as a practical expedient to estimate fair value. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding.

Corporate debt and government debt - Valued at the published market price or prices obtained from independent financial services industry-recognized vendors multiplied by the number of respective units held. Prices obtained from vendors are on the basis of bid or mid evaluations in accordance to a region's market convention, using factors which include but are not limited to market quotations, yields, maturities, and the bond's terms and conditions. Proprietary methods are used to arrive at the evaluated price, which represent the price a dealer would pay for a security.

*Futures contracts*

One of the investment options structured as a separately managed account uses futures contracts as part of its investment strategy. A futures contract represents a commitment for the future purchase or sale of an asset or index at a specified price on a specified date. Futures contracts are exchange-traded and settle daily. Upon entering into the contracts, the investment manager of the separately managed account is required to deposit, either in cash or securities, an amount equal to a certain percentage of the notional value of the contract. Subsequent payments are then made or received by the Plan, depending on the daily fluctuation in the value of the underlying contracts.

As of December 31, 2025 and 2024, the Plan held futures contracts with a notional amount of approximately $998,000 and $629,000, respectively. Notional amounts do not quantify risk or represent assets or liabilities of the Plan, but are used in the calculation of the cash settlements under the contracts. The fair value of these derivative contracts was not material at December 31, 2025 and 2024. Changes in fair value are accounted for as investment income (loss) within net appreciation in fair value of investments and totaled approximately $32,000 for the year ended December 31, 2025.

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

#### Investment Valuation - Continued
*Short sales*

One of the investment options structured as a separately managed account utilizes short sales as part of its investment strategy. Short sales are transactions in which the separately managed account sells an investment it does not own in anticipation of a decline in value of that investment. To complete the transaction, the separately managed account must borrow the investment to make delivery to the buyer. The separately managed account is obligated to replace the investment borrowed by purchasing the investment at market price at the time of replacement. The price at such time may be more or less than the price at which the investment was sold by the separately managed account. When an investment is sold short, a decrease in the value of the investment will be recognized as a gain and an increase in the value of the investment will be recognized as a loss.

The following tables summarize the basis used to measure investment assets and liabilities at fair value at December 31, 2025 and 2024 (dollars in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** |
| **2025** | **Quoted**<br>**Prices in**<br>**Active**<br>**Markets** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs** | <br>**Significant**<br>**Unobservable**<br>**Inputs** | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**Measured at**<br>**NAV** | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br><br>**Total** |
| Assets - Investments: |  |  |  |  |  |
| &nbsp;&nbsp;Common stock | $5585157 | $— | $— | $— | $5585157 |
| &nbsp;&nbsp;Mutual funds | 120058 |  |  |  | 120058 |
| &nbsp;&nbsp;REITs | 23846 |  |  |  | 23846 |
| &nbsp;&nbsp;Collective trust funds |  |  |  | 11120673 | 11120673 |
| &nbsp;&nbsp;Corporate debt |  | 227462 |  |  | 227462 |
| &nbsp;&nbsp;Government debt |  | 184339 |  |  | 184339 |
| &nbsp;&nbsp;Private 40-Act mutual funds |  |  |  | 398213 | 398213 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments, at fair value | $5729061 | $411801 | $— | $11518886 | $17659748 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** |
| **2025** | **Quoted**<br>**Prices in**<br>**Active**<br>**Markets** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**Significant**<br>**Unobservable**<br>**Inputs** | &nbsp;&nbsp;&nbsp;&nbsp;<br><br>**Measured at**<br>**NAV** | &nbsp;&nbsp;&nbsp;&nbsp;<br><br>**Total** |
| Liabilities - Investments sold short: |  |  |  |  |  |
| &nbsp;&nbsp;Government debt | $— | $327342 | $— | $— | $327342 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments sold short, at fair value | $— | $327342 | $— | $— | $327342 |

---

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

#### Investment Valuation - Continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** |
| **2024** | **Quoted**<br>**Prices in**<br>**Active**<br>**Markets** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs** | <br>**Significant**<br>**Unobservable**<br>**Inputs** | <br>**Measured at**<br>**NAV** | <br>**Total** |
| Assets - Investments: |  |  |  |  |  |
| &nbsp;&nbsp;Common stock | $5066260 | $— | $— | $— | $5066260 |
| &nbsp;&nbsp;Mutual funds | 108326 |  |  |  | 108326 |
| &nbsp;&nbsp;REITs | 25888 |  |  |  | 25888 |
| &nbsp;&nbsp;Collective trust funds |  |  |  | 9592890 | 9592890 |
| &nbsp;&nbsp;Corporate debt |  | 235392 |  |  | 235392 |
| &nbsp;&nbsp;Government debt |  | 154812 |  |  | 154812 |
| &nbsp;&nbsp;Private 40-Act mutual funds |  |  |  | 393035 | 393035 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments, at fair value | $5200474 | $390204 | $— | $9985925 | $15576603 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** |
| **2024** | **Quoted**<br>**Prices in**<br>**Active**<br>**Markets** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs** | <br>**Significant**<br>**Unobservable**<br>**Inputs** | <br>**Measured at**<br>**NAV** | <br>**Total** |
| Liabilities - Investments sold short: |  |  |  |  |  |
| &nbsp;&nbsp;Government debt | $— | $19750 | $— | $— | $19750 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments sold short, at fair value | $— | $19750 | $— | $— | $19750 |

---

Participants are permitted to make redemptions from the Plan's investment options on a daily basis, however, certain investments valued at NAV as a practical expedient have redemption requirements and in some cases restrictions for a Plan level redemption. The following tables provide the redemption requirements and restrictions, if any, for those investments as of December 31, 2025 and 2024 (dollars in thousands). In addition, the tables provide the investment strategies for certain investments measured at NAV as a practical expedient, if that investment is a fund that does not file an annual report on Form 5500 as a direct-filing entity.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** |
|  | **Fair value**<br>**(NAV)** | **Redemption**<br>**frequency** | **Redemption**<br>**notice period** | <br>**Restrictions** |
| Funds filing as direct filing entity: |  |  |  |  |
| &nbsp;&nbsp;Collective trusts | $11120673 | Daily | 0 - 5 days |  |
| Funds not filing as direct filing entity: |  |  |  |  |
| &nbsp;&nbsp;Private 40-Act mutual funds |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term fixed income | 398213 | Daily |  | Yes (a) |
|  | $11518886 |  |  |  |

---

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
***Investment Valuation - Continued***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2024** | **2024** | **2024** | **2024** |
|  | **Fair value**<br>**(NAV)** | **Redemption**<br>**frequency** | **Redemption**<br>**notice period** | <br>**Restrictions** |
| Funds filing as direct filing entity: |  |  |  |  |
| &nbsp;&nbsp;Collective trusts | $9592890 | Daily | 0 - 5 days |  |
| Funds not filing as direct filing entity: |  |  |  |  |
| &nbsp;&nbsp;Private 40-Act mutual funds |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term fixed income | 393035 | Daily |  | Yes (a) |
|  | $9985925 |  |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Private 40-Act mutual funds agree to redeem shares solely in cash up to the lesser of $250,000 or 1% of the respective fund's net assets during any 90-day period for any one shareholder. In consideration of the best interests of the remaining shareholders, the Private 40-Act mutual funds reserve the right to pay any redemption proceeds exceeding this amount in whole or in part by a distribution in kind of securities held by the respective fund in lieu of cash. It is highly unlikely that shares would ever be redeemed in kind. Redemption proceeds are ordinarily wired within three business after receipt of the redemption request, but may take up to seven days.

#### Notes Receivable from Participants
Notes receivable from participants are measured at their unpaid balance plus any accrued but unpaid interest. Delinquent loans are reclassified as distributions based upon the terms of the Plan.

#### Income Recognition
Purchases and sales of securities are recorded on a trade-date basis. Interest income is recorded on an accrual basis. Dividends are recorded on the ex-dividend date. Net realized and unrealized appreciation/depreciation is recorded in the accompanying statement of changes in net assets available for benefits as net appreciation in fair value of investments.

#### Contributions
Contributions from Plan participants and the matching contributions from the employer are recorded in the year in which the employee contributions are withheld from compensation. Freedom 2 Save employer contributions, true-up employer matching contributions, and the 3% annual employer contribution are accrued in the year in which they are earned.

#### Administrative Expenses
Participants are charged transaction fees for loan processing, which are included in other expenses and commissions on purchases and sales of Abbott shares and sales of AbbVie stock, which are included in net appreciation in fair value of investments. Investment fees for mutual funds, REITs, collective trusts, and managed accounts are charged against the net assets of the respective fund and are also included in net appreciation in fair value of investments. Abbott pays other recordkeeping and administration fees, where applicable. Expenses that are paid by Abbott are excluded from these financial statements.

#### Payment of Benefits
Benefits are recorded when paid.

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE C - INVESTMENTS
Distributions of Abbott common shares and conversions of participants' common share account balances to participant loans or other investment options are recorded at fair market value.

A summary of Abbott common share data as of December 31, 2025 and 2024 is presented below:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Abbott common shares, 22,899,112 and 24,199,951 shares, respectively (dollars in thousands) | $2869030 | $2737256 |
| Market price per share | $125.29 | $113.11 |

---

#### NOTE D - RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS
The Plan holds units of collective trust funds managed by the Trustee and shares of the Trustee's common stock. A significant portion of the Plan's assets is invested in Abbott common shares.

These transactions qualify as party-in-interest transactions; however, they are exempt from the prohibited transaction rules under ERISA. During 2025, the Plan received $55.5 million in common stock dividends from Abbott.

Participants pay fees to the recordkeeper for loan transaction processing and for commissions on purchases and sales of Abbott shares and sales of AbbVie stock. These transactions qualify as permitted party-in-interest transactions.

#### NOTE E - PLAN TERMINATION
The Plan may be terminated at any time by Abbott upon written notice to the Trustee and Committee. All participants' account balances would become fully vested upon Plan termination. Upon termination of the Plan, distributions of each participant's share in the Trust, as determined by the terms of the Plan, would be made to each participant. At the present time, Abbott has no intention of terminating the Plan.

#### NOTE F - TAX STATUS
The Internal Revenue Service ("IRS") has determined and informed Abbott by a letter dated April 13, 2022, that the Plan and related Trust are designed in accordance with applicable sections of the IRC. The Plan has been amended since the applicable date of the determination letter. However, the Plan administrator believes that the Plan is designed and is currently being operated, in all material respects, in accordance with the applicable requirements of the IRC.

Accounting principles generally accepted in the United States of America require Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the organization has taken an uncertain position that more likely than not would not be sustained upon examination by the IRS or other applicable taxing authorities. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2025 and 2024, there are no uncertain positions taken or expected to be taken that would require recognition of a liability or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions. There are currently no audits in progress.

#### Abbott Laboratories Stock Retirement Plan

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE G - RISKS AND UNCERTAINTIES
In general, the investments provided by the Plan are exposed to various risks, such as interest rate, credit and overall market volatility risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participant accounts and the amounts reported in the statements of net assets available for benefits.

#### NOTE H - SUBSEQUENT EVENTS
Management of the Plan has evaluated subsequent events from December 31, 2025 through the date these financial statements were issued. Other than described below, management of the Plan is not aware of any subsequent events that require recognition or additional disclosure in these financial statements.

The following changes took effect on January 1, 2026:

Fidelity Investments replaced Alight Solutions as the recordkeeper of the Plan. For the Abbott and AbbVie common stock investment options only, Fidelity Management Trust Company replaced The Northern Trust Company as custodian and trustee.

An enrolled Freedom 2 Save participant who makes elective deferrals to the Plan will receive employer matching contributions each payroll period instead of a true-up employer matching contribution shortly after the end of the year. The sum of an enrolled Freedom 2 Save participant's employer matching contributions and Freedom 2 Save employer contribution will not exceed 5% of the participant's eligible earnings for the plan year. Additionally, Freedom 2 Save participants will not be required to be actively employed or on a qualifying leave of absence on the last day of the plan year in order to receive the Freedom 2 Save employer contribution.

A participant who has a balance in the AbbVie common stock investment option will have dividends invested across the participant's investment elections on file for future contributions.

Non-vested portions of employer contributions and earnings thereon are forfeited as of the date the participating employee receives a distribution or, if later, the end of the plan year in which the participating employee has been separated from Abbott for a period of five years.

SUPPLEMENTAL SCHEDULE

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | <br>**(e) Current**<br>**value** |
|  | **Common stock - employer securities** |  |  |  |
| \* | &nbsp;&nbsp;ABBOTT LABORATORIES, common shares |  |  | $2869030 |
|  | **Common stock** |  |  |  |
|  | &nbsp;&nbsp;5TH 3RD BANCORP COM |  |  | 964 |
|  | &nbsp;&nbsp;ABBVIE INC. |  |  | 2445873 |
|  | &nbsp;&nbsp;ACADIA HEALTHCARE CO INC COM |  |  | 40 |
|  | &nbsp;&nbsp;ACUITY INC |  |  | 343 |
|  | &nbsp;&nbsp;ADT INC DEL COM |  |  | 128 |
|  | &nbsp;&nbsp;ADVANCED DRAIN SYS INC DEL COM |  |  | 317 |
|  | &nbsp;&nbsp;AECOM |  |  | 391 |
|  | &nbsp;&nbsp;AES CORP COM |  |  | 315 |
|  | &nbsp;&nbsp;AFFILIATED MANAGERS GROUP INC COM STK |  |  | 240 |
|  | &nbsp;&nbsp;AFFIRM HLDGS INC CL A |  |  | 257 |
|  | &nbsp;&nbsp;AGCO CORP COM |  |  | 203 |
|  | &nbsp;&nbsp;AGILENT TECHNOLOGIES INC COM |  |  | 1199 |
|  | &nbsp;&nbsp;AIR LEASE CORP CL A |  |  | 208 |
|  | &nbsp;&nbsp;AKAMAI TECHNOLOGIES INC COM STK |  |  | 380 |
|  | &nbsp;&nbsp;ALASKA AIR GROUP INC COM |  |  | 146 |
|  | &nbsp;&nbsp;ALBEMARLE CORP COM |  |  | 518 |
|  | &nbsp;&nbsp;ALBERTSONS COS INC CL A |  |  | 208 |
|  | &nbsp;&nbsp;ALIGN TECHNOLOGY INC COM |  |  | 331 |
|  | &nbsp;&nbsp;ALLEGION PLC COMMON STOCK |  |  | 426 |
|  | &nbsp;&nbsp;ALLEGRO MICROSYSTEMS INC DEL COM |  |  | 103 |
|  | &nbsp;&nbsp;ALLIANT ENERGY CORP COM |  |  | 509 |
|  | &nbsp;&nbsp;ALLISON TRANSMISSION HOLDING |  |  | 208 |
|  | &nbsp;&nbsp;ALLSTATE CORP COM |  |  | 1700 |
|  | &nbsp;&nbsp;ALLY FINL INC COM |  |  | 342 |
|  | &nbsp;&nbsp;AMCOR |  |  | 595 |
|  | &nbsp;&nbsp;AMDOCS ORD GBP0.01 |  |  | 272 |
|  | &nbsp;&nbsp;AMENTUM HLDGS INC COM |  |  | 145 |
|  | &nbsp;&nbsp;AMER FINL GROUP INC OH COM STK |  |  | 280 |
|  | &nbsp;&nbsp;AMER SPORTS INC COM |  |  | 174 |
|  | &nbsp;&nbsp;AMEREN CORP COM |  |  | 824 |
|  | &nbsp;&nbsp;AMERICAN AIRLINES INC COM |  |  | 295 |
|  | &nbsp;&nbsp;AMERICAN WTR WKS CO INC NEW COM |  |  | 787 |
|  | &nbsp;&nbsp;AMERIPRISE FINL INC COM |  |  | 130 |
|  | &nbsp;&nbsp;AMETEK INC NEW COM |  |  | 1464 |
|  | &nbsp;&nbsp;AMKOR TECHNOLOGY INC COM |  |  | 136 |
|  | &nbsp;&nbsp;ANGLOGOLD ASHANTI PLC ORD  |  |  | 1162 |
|  | &nbsp;&nbsp;ANTERO MIDSTREAM CORPORATION |  |  | 185 |
|  | &nbsp;&nbsp;ANTERO RES CORP COM |  |  | 307 |
|  | &nbsp;&nbsp;APA CORP COM |  |  | 271 |
|  | &nbsp;&nbsp;API GROUP CORPORATION COM |  |  | 431 |
|  | &nbsp;&nbsp;APPLIED INDL TECHNOLOGIES INC COM |  |  | 297 |
|  | &nbsp;&nbsp;APTARGROUP INC COM |  |  | 247 |
|  | &nbsp;&nbsp;APTIV PLC NEW ORD |  |  | 511 |
|  | &nbsp;&nbsp;ARAMARK COM |  |  | 296 |
|  | &nbsp;&nbsp;ARCH CAPITAL GROUP COM STK |  |  | 1056 |
|  | &nbsp;&nbsp;ARCHER-DANIELS-MIDLAND CO COM |  |  | 849 |
|  | &nbsp;&nbsp;ARMSTRONG WORLD INDS INC NEW COM STK |  |  | 180 |
|  | &nbsp;&nbsp;ARROW ELECTR INC COM |  |  | 175 |
|  | &nbsp;&nbsp;ASHLAND INC COM |  |  | 82 |
|  | &nbsp;&nbsp;ASSURANT INC COM |  |  | 377 |
|  | &nbsp;&nbsp;ASSURED GUARANTY LTD COMMON STK |  |  | 121 |
|  | &nbsp;&nbsp;AST SPACEMOBILE INC CL A CL A |  |  | 37 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | <br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;ATI INC COM |  |  | 478 |
|  | &nbsp;&nbsp;ATMOS ENERGY CORP COM |  |  | 833 |
|  | &nbsp;&nbsp;AURORA INNOVATION INC CL A COM |  |  | 138 |
|  | &nbsp;&nbsp;AUTONATION INC COM |  |  | 168 |
|  | &nbsp;&nbsp;AVANTOR INC COM |  |  | 234 |
|  | &nbsp;&nbsp;AVERY DENNISON CORP COM |  |  | 432 |
|  | &nbsp;&nbsp;AVIS BUDGET GROUP INC COM STK |  |  | 47 |
|  | &nbsp;&nbsp;AVNET INC COM |  |  | 117 |
|  | &nbsp;&nbsp;AXALTA COATING SYSTEMS LTD COM |  |  | 213 |
|  | &nbsp;&nbsp;AXIS CAPITAL HOLDINGS LTD COM |  |  | 245 |
|  | &nbsp;&nbsp;BAKER HUGHES CO |  |  | 1396 |
|  | &nbsp;&nbsp;BALL CORP COM |  |  | 446 |
|  | &nbsp;&nbsp;BANK NEW YORK MELLON CORP COM STK |  |  | 2329 |
|  | &nbsp;&nbsp;BANK OZK COM |  |  | 152 |
|  | &nbsp;&nbsp;BATH & BODY WORKS INC COM |  |  | 128 |
|  | &nbsp;&nbsp;BAXTER INTL INC COM |  |  | 306 |
|  | &nbsp;&nbsp;BELLRING BRANDS INC COM |  |  | 104 |
|  | &nbsp;&nbsp;BERKLEY W R CORP COM |  |  | 631 |
|  | &nbsp;&nbsp;BEST BUY INC COM STK |  |  | 401 |
|  | &nbsp;&nbsp;BILL HOLDINGS INC COM |  |  | 157 |
|  | &nbsp;&nbsp;BIO RAD LABORATORIES INC CL A CL A |  |  | 174 |
|  | &nbsp;&nbsp;BIOGEN INC COMMON STOCK |  |  | 792 |
|  | &nbsp;&nbsp;BIOMARIN PHARMACEUTICAL INC COM |  |  | 348 |
|  | &nbsp;&nbsp;BIO-TECHNE CORP COM |  |  | 279 |
|  | &nbsp;&nbsp;BIRKENSTOCK HOLDING PLC COM NPV |  |  | 49 |
|  | &nbsp;&nbsp;BJS WHSL CLUB HLDGS INC COM |  |  | 310 |
|  | &nbsp;&nbsp;BLOCK H & R INC COM |  |  | 142 |
|  | &nbsp;&nbsp;BLOCK INC |  |  | 687 |
|  | &nbsp;&nbsp;BOK FINL CORP COM NEW |  |  | 79 |
|  | &nbsp;&nbsp;BORG WARNER INC COM |  |  | 295 |
|  | &nbsp;&nbsp;BOSTON BEER INC CL A CL A |  |  | 51 |
|  | &nbsp;&nbsp;BOYD GAMING CORP COM |  |  | 148 |
|  | &nbsp;&nbsp;BRIGHT HORIZONS FA COM |  |  | 154 |
|  | &nbsp;&nbsp;BRIGHTHOUSE FINL INC COM |  |  | 114 |
|  | &nbsp;&nbsp;BROADRIDGE FINL SOLUTIONS INC COM STK |  |  | 76 |
|  | &nbsp;&nbsp;BROOKFIELD RENEWABLE CORP NEW CL A |  |  | 161 |
|  | &nbsp;&nbsp;BROWN & BROWN INC COM |  |  | 638 |
|  | &nbsp;&nbsp;BROWN FORMAN CORP CL A CL A |  |  | 36 |
|  | &nbsp;&nbsp;BROWN-FORMAN INC CL B NON-VTG COM |  |  | 119 |
|  | &nbsp;&nbsp;BRUKER CORP |  |  | 151 |
|  | &nbsp;&nbsp;BRUNSWICK CORP COM |  |  | 150 |
|  | &nbsp;&nbsp;BUILDERS FIRSTSOURCE INC COM STK |  |  | 345 |
|  | &nbsp;&nbsp;BUNGE GLOBAL SA F COMMON STOCK |  |  | 371 |
|  | &nbsp;&nbsp;BWX TECHNOLOGIES INC COM |  |  | 401 |
|  | &nbsp;&nbsp;C H ROBINSON WORLDWIDE INC COM NEW |  |  | 584 |
|  | &nbsp;&nbsp;CACI INTL INC CL A CL A |  |  | 358 |
|  | &nbsp;&nbsp;CAESARS ENTMT INC NEW COM |  |  | 146 |
|  | &nbsp;&nbsp;CARDINAL HLTH INC |  |  | 754 |
|  | &nbsp;&nbsp;CARIS LIFE SCIENCES INC COM |  |  | 10 |
|  | &nbsp;&nbsp;CARLISLE COMPANIES INC COM |  |  | 361 |
|  | &nbsp;&nbsp;CARLYLE GROUP INC COM |  |  | 479 |
|  | &nbsp;&nbsp;CARMAX INC COM |  |  | 175 |
|  | &nbsp;&nbsp;CARNIVAL CORP COM PAIRED |  |  | 707 |
|  | &nbsp;&nbsp;CARPENTER TECHNOLOGY CORP COM |  |  | 386 |
|  | &nbsp;&nbsp;CASEYS GEN STORES INC COM |  |  | 536 |
|  | &nbsp;&nbsp;CBOE GLOBAL MARKETS INC |  |  | 821 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;CBRE GROUP INC CL A CL A |  |  | 1316 |
|  | &nbsp;&nbsp;CCC INTELLIGENT SOLUTIONS HLDGS INC COM |  |  | 140 |
|  | &nbsp;&nbsp;CDW CORP COM |  |  | 511 |
|  | &nbsp;&nbsp;CELANESE CORP DEL COM STK |  |  | 143 |
|  | &nbsp;&nbsp;CENTENE CORP DEL COM |  |  | 619 |
|  | &nbsp;&nbsp;CENTERPOINT ENERGY INC COM |  |  | 774 |
|  | &nbsp;&nbsp;CERTARA INC COM |  |  | 35 |
|  | &nbsp;&nbsp;CF INDS HLDGS INC COM |  |  | 386 |
|  | &nbsp;&nbsp;CHARLES RIV LABORATORIES INTL INC COM |  |  | 303 |
|  | &nbsp;&nbsp;CHARTER COMMUNICATIONS INC NEW CL A CL A |  |  | 539 |
|  | &nbsp;&nbsp;CHEMED CORP NEW COM |  |  | 168 |
|  | &nbsp;&nbsp;CHENIERE ENERGY INC COM NEW |  |  | 706 |
|  | &nbsp;&nbsp;CHOICE HOTELS INTL INC COM |  |  | 57 |
|  | &nbsp;&nbsp;CHORD ENERGY CORPORATION COM |  |  | 162 |
|  | &nbsp;&nbsp;CHURCH & DWIGHT INC COM |  |  | 635 |
|  | &nbsp;&nbsp;CHURCHILL DOWNS INC COM  |  |  | 36 |
|  | &nbsp;&nbsp;CIENA CORP COM NEW |  |  | 1021 |
|  | &nbsp;&nbsp;CIN FNCL CORP COM |  |  | 768 |
|  | &nbsp;&nbsp;CIRCLE INTERNET GROUP INC. COM |  |  | 99 |
|  | &nbsp;&nbsp;CIRRUS LOGIC INC COM |  |  | 188 |
|  | &nbsp;&nbsp;CITIZENS FINL GROUP INC COM |  |  | 782 |
|  | &nbsp;&nbsp;CLARIVATE PLC |  |  | 38 |
|  | &nbsp;&nbsp;CLEAN HBRS INC COM |  |  | 367 |
|  | &nbsp;&nbsp;CLEARWAY ENERGY INC CL A CL A |  |  | 35 |
|  | &nbsp;&nbsp;CLEARWAY ENERGY INC CL C CL C |  |  | 83 |
|  | &nbsp;&nbsp;CLEVELAND CLIFFS |  |  | 229 |
|  | &nbsp;&nbsp;CLOROX CO COMMON STOCK  |  |  | 381 |
|  | &nbsp;&nbsp;CMS ENERGY CORP COM |  |  | 662 |
|  | &nbsp;&nbsp;CNA FNCL CORP COM |  |  | 30 |
|  | &nbsp;&nbsp;CNH INDUSTRIAL NV COM STK |  |  | 254 |
|  | &nbsp;&nbsp;COCA-COLA CONSOLIDATED INC COM |  |  | 212 |
|  | &nbsp;&nbsp;COGNEX CORP COM |  |  | 192 |
|  | &nbsp;&nbsp;COGNIZANT TECH SOLUTIONS CORP CL A |  |  | 1240 |
|  | &nbsp;&nbsp;COHERENT CORP COM |  |  | 887 |
|  | &nbsp;&nbsp;COINBASE GLOBAL INC COM CL A |  |  | 1407 |
|  | &nbsp;&nbsp;COLUMBIA BKG SYS INC COM |  |  | 255 |
|  | &nbsp;&nbsp;COLUMBIA SPORTSWEAR CO COM |  |  | 44 |
|  | &nbsp;&nbsp;COM ALCOA CORPORATION COM |  |  | 426 |
|  | &nbsp;&nbsp;COMM BANCSHARES INC COM |  |  | 208 |
|  | &nbsp;&nbsp;CONAGRA BRANDS INC COM |  |  | 254 |
|  | &nbsp;&nbsp;CONCENTRIX CORP |  |  | 57 |
|  | &nbsp;&nbsp;CONS EDISON INC COM |  |  | 1109 |
|  | &nbsp;&nbsp;CONSTELLATION BRANDS INC CL A CL A  |  |  | 607 |
|  | &nbsp;&nbsp;CORE & MAIN INC COM CL A COM CL A |  |  | 128 |
|  | &nbsp;&nbsp;COREBRIDGE FINL INC COM |  |  | 245 |
|  | &nbsp;&nbsp;CORNING INC COM |  |  | 2107 |
|  | &nbsp;&nbsp;CORTEVA INC COM |  |  | 1419 |
|  | &nbsp;&nbsp;COSTAR GROUP INC COM |  |  | 757 |
|  | &nbsp;&nbsp;COTERRA ENERGY INC COM |  |  | 614 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;COTY INC COM CL A COM CL A |  |  | 34 |
|  | &nbsp;&nbsp;CRANE CO NEW COM |  |  | 280 |
|  | &nbsp;&nbsp;CRANE NXT CO COM |  |  | 71 |
|  | &nbsp;&nbsp;CREDIT ACCEP CORP MICH COM |  |  | 55 |
|  | &nbsp;&nbsp;CROCS INC COM |  |  | 133 |
|  | &nbsp;&nbsp;CROWN HLDGS INC COM |  |  | 369 |
|  | &nbsp;&nbsp;CULLEN / FROST BANKERS INC COM |  |  | 239 |
|  | &nbsp;&nbsp;CUMMINS INC |  |  | 2174 |
|  | &nbsp;&nbsp;CURTISS WRIGHT CORP COM |  |  | 636 |
|  | &nbsp;&nbsp;D R HORTON INC COM |  |  | 1184 |
|  | &nbsp;&nbsp;DARDEN RESTAURANTS INC COM |  |  | 31 |
|  | &nbsp;&nbsp;DARLING INGREDIENTS INC COMSTK |  |  | 154 |
|  | &nbsp;&nbsp;DAYFORCE INC  |  |  | 299 |
|  | &nbsp;&nbsp;DELTA AIR LINES INC DEL COM NEW COM NEW |  |  | 1394 |
|  | &nbsp;&nbsp;DENTSPLY SIRONA INC COM |  |  | 71 |
|  | &nbsp;&nbsp;DEVON ENERGY CORP NEW COM |  |  | 710 |
|  | &nbsp;&nbsp;DIAMONDBACK ENERGY INC COM |  |  | 873 |
|  | &nbsp;&nbsp;DICKS SPORTING GOODS INC OC-COM OC-COM |  |  | 384 |
|  | &nbsp;&nbsp;DILLARDS INC CL A COM |  |  | 54 |
|  | &nbsp;&nbsp;DOCUSIGN INC COM |  |  | 106 |
|  | &nbsp;&nbsp;DOLBY LABORATORIES INC CL A COM STK |  |  | 118 |
|  | &nbsp;&nbsp;DOLLAR GEN CORP NEW COM |  |  | 902 |
|  | &nbsp;&nbsp;DOLLAR TREE INC COM STK |  |  | 732 |
|  | &nbsp;&nbsp;DOMINOS PIZZA INC COM |  |  | 282 |
|  | &nbsp;&nbsp;DONALDSON INC COM |  |  | 313 |
|  | &nbsp;&nbsp;DOUBLEVERIFY HLDGS INC COM |  |  | 25 |
|  | &nbsp;&nbsp;DOVER CORP COM  |  |  | 818 |
|  | &nbsp;&nbsp;DOW INC |  |  | 514 |
|  | &nbsp;&nbsp;DROPBOX INC CL A CL A |  |  | 116 |
|  | &nbsp;&nbsp;DT MIDSTREAM INC COM |  |  | 372 |
|  | &nbsp;&nbsp;DTE ENERGY CO COM |  |  | 831 |
|  | &nbsp;&nbsp;DUPONT DE NEMOURS INC COMMON STOCK |  |  | 522 |
|  | &nbsp;&nbsp;DXC TECHNOLOGY CO COM |  |  | 86 |
|  | &nbsp;&nbsp;E L F BEAUTY INC COM |  |  | 130 |
|  | &nbsp;&nbsp;EAGLE MATLS INC COM |  |  | 190 |
|  | &nbsp;&nbsp;EAST WEST BANCORP INC COM |  |  | 474 |
|  | &nbsp;&nbsp;EASTMAN CHEM CO COM |  |  | 226 |
|  | &nbsp;&nbsp;EBAY INC COM  |  |  | 1238 |
|  | &nbsp;&nbsp;EDISON INTL COM |  |  | 708 |
|  | &nbsp;&nbsp;ELANCO ANIMAL HEALTH INC COM |  |  | 344 |
|  | &nbsp;&nbsp;ELECTR ARTS COM |  |  | 1584 |
|  | &nbsp;&nbsp;ELEMENT SOLUTION INC COM |  |  | 175 |
|  | &nbsp;&nbsp;EMCOR GROUP INC COM |  |  | 549 |
|  | &nbsp;&nbsp;ENCOMPASS HEALTH CORP COM  |  |  | 329 |
|  | &nbsp;&nbsp;ENTEGRIS INC COM |  |  | 324 |
|  | &nbsp;&nbsp;ENTERGY CORP NEW COM |  |  | 1273 |
|  | &nbsp;&nbsp;ENVISTA HLDGS CORP COM |  |  | 113 |
|  | &nbsp;&nbsp;EPAM SYS INC COM STK |  |  | 341 |
|  | &nbsp;&nbsp;EQT CORP COM |  |  | 1031 |
|  | &nbsp;&nbsp;EQUIFAX INC COM |  |  | 678 |
|  | &nbsp;&nbsp;ESAB CORPORATION COM  |  |  | 196 |
|  | &nbsp;&nbsp;ESSENTIAL UTILS INC COM |  |  | 334 |
|  | &nbsp;&nbsp;ESTEE LAUDER COMPANIES INC CL A  |  |  | 794 |
|  | &nbsp;&nbsp;ETSY INC COM |  |  | 72 |
|  | &nbsp;&nbsp;EURONET WORLDWIDE INC COM |  |  | 90 |
|  | &nbsp;&nbsp;EVERCORE INC |  |  | 389 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;EVERCORE INC |  |  | 389 |
|  | &nbsp;&nbsp;EVEREST GROUP LTD |  |  | 374 |
|  | &nbsp;&nbsp;EVERGY INC COM NPV |  |  | 515 |
|  | &nbsp;&nbsp;EVERSOURCE ENERGY COM |  |  | 775 |
|  | &nbsp;&nbsp;EVERUS CONSTR GROUP INC COM |  |  | 138 |
|  | &nbsp;&nbsp;EXACT SCIENCES CORP COM |  |  | 556 |
|  | &nbsp;&nbsp;EXELIXIS INC COM STK |  |  | 68 |
|  | &nbsp;&nbsp;EXELON CORP COM |  |  | 1365 |
|  | &nbsp;&nbsp;EXPAND ENERGY CORP |  |  | 776 |
|  | &nbsp;&nbsp;EXPEDITORS INTL WASH INC COM |  |  | 621 |
|  | &nbsp;&nbsp;F N B CORP PA COM |  |  | 186 |
|  | &nbsp;&nbsp;F&G ANNUITIES & LIFE INC COM |  |  | 15 |
|  | &nbsp;&nbsp;F5 INC COM STK NPV |  |  | 455 |
|  | &nbsp;&nbsp;FACTSET RESH SYS INC COM STK |  |  | 315 |
|  | &nbsp;&nbsp;FAIR ISAAC CORPORATION COM |  |  | 216 |
|  | &nbsp;&nbsp;FASTENAL CO COM |  |  | 253 |
|  | &nbsp;&nbsp;FERGUSON ENTERPRISES INC  |  |  | 1240 |
|  | &nbsp;&nbsp;FERMI INC COM USD0.001 |  |  | 10 |
|  | &nbsp;&nbsp;FIDELITY NATL FINL INC  |  |  | 435 |
|  | &nbsp;&nbsp;FIDELITY NATL INFORMATION SVCS INC COM STK |  |  | 1082 |
|  | &nbsp;&nbsp;FIFTH THIRD BANK |  |  | 343 |
|  | &nbsp;&nbsp;FIGURE TECHNOLOGY SOLUTIONS INC CL A CL A |  |  | 36 |
|  | &nbsp;&nbsp;FIRST AMERN FINL CORP COM STK |  |  | 190 |
|  | &nbsp;&nbsp;FIRST CTZNS BANCSHARES INC CL A CL A |  |  | 601 |
|  | &nbsp;&nbsp;FIRST HAWAIIAN INC COM |  |  | 100 |
|  | &nbsp;&nbsp;FIRST HORIZON CORPORATION COM  |  |  | 368 |
|  | &nbsp;&nbsp;FIRST SOLAR INC COM |  |  | 821 |
|  | &nbsp;&nbsp;FIRSTENERGY CORP COM |  |  | 764 |
|  | &nbsp;&nbsp;FIVE BELOW INC COM USD0.01 |  |  | 313 |
|  | &nbsp;&nbsp;FLEX LTD COM USD0.01 |  |  | 695 |
|  | &nbsp;&nbsp;FLOOR & DECOR HLDGS INC CL A CL A |  |  | 138 |
|  | &nbsp;&nbsp;FLOWERS FOODS INC COM |  |  | 66 |
|  | &nbsp;&nbsp;FLOWSERVE CORP COM |  |  | 284 |
|  | &nbsp;&nbsp;FLUTTER ENTERTAINMENT PLC  |  |  | 182 |
|  | &nbsp;&nbsp;FMC CORP COM (NEW) |  |  | 54 |
|  | &nbsp;&nbsp;FORD MTR CO  |  |  | 1579 |
|  | &nbsp;&nbsp;FORTIVE CORP COM MON STOCK |  |  | 539 |
|  | &nbsp;&nbsp;FORTUNE BRANDS INNOVATIONS INC  |  |  | 186 |
|  | &nbsp;&nbsp;FOX CORP CL A CL A |  |  | 477 |
|  | &nbsp;&nbsp;FOX CORP CL B CL B |  |  | 305 |
|  | &nbsp;&nbsp;FREEDOM HLDG CORP COM NEW COM  |  |  | 12 |
|  | &nbsp;&nbsp;FRESHPET INC COM |  |  | 64 |
|  | &nbsp;&nbsp;FRKLN RES INC COM |  |  | 227 |
|  | &nbsp;&nbsp;FRONTIER AIRLINES |  |  | 286 |
|  | &nbsp;&nbsp;FTI CONSULTING INC COM |  |  | 166 |
|  | &nbsp;&nbsp;GAMESTOP CORP NEW CL A |  |  | 257 |
|  | &nbsp;&nbsp;GAP INC COM |  |  | 179 |
|  | &nbsp;&nbsp;GARMIN LTD COMMON STOCK |  |  | 1019 |
|  | &nbsp;&nbsp;GATES INDL CORP PL COM  |  |  | 169 |
|  | &nbsp;&nbsp;GCI LIBERTY INC COM SER C |  |  | 31 |
|  | &nbsp;&nbsp;GCI LIBERTY INC SER A GCI GROUP COM |  |  | 4 |
|  | &nbsp;&nbsp;GE HEALTHCARE TECHNOLOGIES INC COM |  |  | 1152 |
|  | &nbsp;&nbsp;GEN DIGITAL INC COM  |  |  | 412 |
|  | &nbsp;&nbsp;GENERAC HLDGS INC COM STK |  |  | 248 |
|  | &nbsp;&nbsp;GENERAL MILLS INC COM |  |  | 784 |
|  | &nbsp;&nbsp;GENPACT LIMITED COM STK  |  |  | 233 |
|  | &nbsp;&nbsp;GENTEX CORP COM |  |  | 163 |
|  | &nbsp;&nbsp;GENUINE PARTS CO COM |  |  | 526 |
|  | &nbsp;&nbsp;GLOBAL PMTS INC COM |  |  | 576 |
|  | &nbsp;&nbsp;GLOBALFOUNDRIES INC |  |  | 110 |
|  | &nbsp;&nbsp;GLOBANT SA  |  |  | 79 |
|  | &nbsp;&nbsp;GLOBE LIFE INC COM |  |  | 361 |
|  | &nbsp;&nbsp;GLOBUS MED INC CL A NEW COM STK |  |  | 306 |
|  | &nbsp;&nbsp;GRACO INC COM |  |  | 421 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;GRAINGER W W INC COM |  |  | 200 |
|  | &nbsp;&nbsp;GRAND CANYON ED INC COM STK |  |  | 100 |
|  | &nbsp;&nbsp;GRAPHIC PACKAGING HLDG CO COM STK |  |  | 136 |
|  | &nbsp;&nbsp;GXO LOGISTICS INC COM |  |  | 182 |
|  | &nbsp;&nbsp;HALLIBURTON CO COM |  |  | 739 |
|  | &nbsp;&nbsp;HAMILTON LANE INC CL A CL A |  |  | 59 |
|  | &nbsp;&nbsp;HANOVER INS GROUP INC COM |  |  | 198 |
|  | &nbsp;&nbsp;HARLEY DAVIDSON COM  |  |  | 69 |
|  | &nbsp;&nbsp;HASBRO INC COM |  |  | 337 |
|  | &nbsp;&nbsp;HAYWARD HLDGS INC COM |  |  | 95 |
|  | &nbsp;&nbsp;HENRY SCHEIN INC COMMON STOCK |  |  | 246 |
|  | &nbsp;&nbsp;HERSHEY COMPANY COM STK USD1 |  |  | 721 |
|  | &nbsp;&nbsp;HEWLETT PACKARD ENTERPRISE CO COM |  |  | 973 |
|  | &nbsp;&nbsp;HEXCEL CORP NEW COM |  |  | 180 |
|  | &nbsp;&nbsp;HF SINCLAIR CORPORATION COM |  |  | 199 |
|  | &nbsp;&nbsp;HOLOGIC INC COM |  |  | 516 |
|  | &nbsp;&nbsp;HORMEL FOODS CORP COM |  |  | 212 |
|  | &nbsp;&nbsp;HOULIHAN LOKEY INC CL A CL A |  |  | 184 |
|  | &nbsp;&nbsp;HOWARD HUGHES HLDGS INC COM  |  |  | 76 |
|  | &nbsp;&nbsp;HP INC COM |  |  | 648 |
|  | &nbsp;&nbsp;HUBBELL INC COM |  |  | 730 |
|  | &nbsp;&nbsp;HUMANA INC COM |  |  | 953 |
|  | &nbsp;&nbsp;HUNT J B TRANS SVCS INC COM |  |  | 465 |
|  | &nbsp;&nbsp;HUNTINGTON BANCSHARES INC COM |  |  | 831 |
|  | &nbsp;&nbsp;HUNTINGTON INGALLS INDS INC COM |  |  | 413 |
|  | &nbsp;&nbsp;HUNTSMAN CORP COM STK |  |  | 50 |
|  | &nbsp;&nbsp;HYATT HOTELS CORP COM CL A COM CL A |  |  | 202 |
|  | &nbsp;&nbsp;IAC INC COM NEW |  |  | 79 |
|  | &nbsp;&nbsp;IDACORP INC COM |  |  | 212 |
|  | &nbsp;&nbsp;IDEX CORP COM |  |  | 416 |
|  | &nbsp;&nbsp;ILLUMINA INC COM |  |  | 634 |
|  | &nbsp;&nbsp;INCYTE CORP COM |  |  | 358 |
|  | &nbsp;&nbsp;INGERSOLL RAND INC COM |  |  | 973 |
|  | &nbsp;&nbsp;INGRAM MICRO HLDG CORP COM |  |  | 11 |
|  | &nbsp;&nbsp;INGREDION INC COM |  |  | 217 |
|  | &nbsp;&nbsp;INSMED INC COM  |  |  | 71 |
|  | &nbsp;&nbsp;INTL FLAVORS & FRAGRANCES INC COM |  |  | 528 |
|  | &nbsp;&nbsp;INTL PAPER CO COM |  |  | 639 |
|  | &nbsp;&nbsp;INVESCO LTD COM STK  |  |  | 296 |
|  | &nbsp;&nbsp;IONIS PHARMACEUTICALS INC COM |  |  | 32 |
|  | &nbsp;&nbsp;IPG PHOTONICS CORP COM |  |  | 54 |
|  | &nbsp;&nbsp;IQVIA HLDGS INC COM  |  |  | 1173 |
|  | &nbsp;&nbsp;IRIDIUM COMMUNICATIONS INC COM STK |  |  | 45 |
|  | &nbsp;&nbsp;ITT INC COM |  |  | 452 |
|  | &nbsp;&nbsp;JABIL INC COM  |  |  | 258 |
|  | &nbsp;&nbsp;JACK HENRY & ASSOC INC COM |  |  | 406 |
|  | &nbsp;&nbsp;JACOBS SOLUTIONS INC COM |  |  | 488 |
|  | &nbsp;&nbsp;JAMES HARDIE INDUSTRIES PLC COM |  |  | 34 |
|  | &nbsp;&nbsp;JANUS HENDERSON GROUP PLC  |  |  | 181 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;JAZZ PHARMACEUTICALS PLC COM  |  |  | 305 |
|  | &nbsp;&nbsp;JEFFERIES FINL GROUP INC COM |  |  | 222 |
|  | &nbsp;&nbsp;JONES LANG LASALLE INC COM STK |  |  | 357 |
|  | &nbsp;&nbsp;KBR INC COM |  |  | 144 |
|  | &nbsp;&nbsp;KEMPER CORP DEL COM |  |  | 79 |
|  | &nbsp;&nbsp;KENVUE INC COM |  |  | 1010 |
|  | &nbsp;&nbsp;KEYCORP NEW COM |  |  | 603 |
|  | &nbsp;&nbsp;KEYSIGHT TECHNOLOGIES INC COM |  |  | 1074 |
|  | &nbsp;&nbsp;KINDER MORGAN INC DEL COM |  |  | 1652 |
|  | &nbsp;&nbsp;KIRBY CORP COM |  |  | 191 |
|  | &nbsp;&nbsp;KNIGHT-SWIFT TRANSN HLDGS INC CL A  |  |  | 253 |
|  | &nbsp;&nbsp;KRAFT HEINZ CO COM |  |  | 640 |
|  | &nbsp;&nbsp;KROGER CO COM |  |  | 1177 |
|  | &nbsp;&nbsp;KYNDRYL HLDGS INC COM |  |  | 177 |
|  | &nbsp;&nbsp;L3HARRIS TECHNOLOGIES INC COM |  |  | 1688 |
|  | &nbsp;&nbsp;LABCORP HLDGS INC COM |  |  | 649 |
|  | &nbsp;&nbsp;LAMB WESTON HLDGS INC COM  |  |  | 175 |
|  | &nbsp;&nbsp;LANDSTAR SYS INC COM |  |  | 156 |
|  | &nbsp;&nbsp;LATTICE SEMICONDUCTOR CORP COM |  |  | 46 |
|  | &nbsp;&nbsp;LEAR CORP COM NEW COM NEW |  |  | 183 |
|  | &nbsp;&nbsp;LEIDOS HLDGS INC COM |  |  | 712 |
|  | &nbsp;&nbsp;LENNAR CORP CL A CL A |  |  | 654 |
|  | &nbsp;&nbsp;LENNAR CORP CL B CL B |  |  | 24 |
|  | &nbsp;&nbsp;LEONARDO DRS INC COM |  |  | 50 |
|  | &nbsp;&nbsp;LIBERTY BROADBAND CORP COM SER A COM SERA |  |  | 12 |
|  | &nbsp;&nbsp;LIBERTY BROADBAND CORP COM SER C COM SERC |  |  | 141 |
|  | &nbsp;&nbsp;LIBERTY GLOBAL LTD. COM USD0.01 CLASS C |  |  | 50 |
|  | &nbsp;&nbsp;LIBERTY GLOBAL LTD. COMMON STOCK |  |  | 51 |
|  | &nbsp;&nbsp;LIBERTY LIVE HLDGS INC COM SER A |  |  | 49 |
|  | &nbsp;&nbsp;LIBERTY LIVE HLDGS INC SER C  |  |  | 119 |
|  | &nbsp;&nbsp;LIBERTY MEDIA CORP SER A |  |  | 39 |
|  | &nbsp;&nbsp;LIBERTY MEDIA CORP SER C |  |  | 446 |
|  | &nbsp;&nbsp;LINCOLN ELEC HLDGS INC COM |  |  | 403 |
|  | &nbsp;&nbsp;LINCOLN NATL CORP COM |  |  | 233 |
|  | &nbsp;&nbsp;LITHIA MTRS INC COM CL A |  |  | 232 |
|  | &nbsp;&nbsp;LITTELFUSE INC COM |  |  | 192 |
|  | &nbsp;&nbsp;LKQ CORP COM LKQ CORP |  |  | 240 |
|  | &nbsp;&nbsp;LOAR HOLDINGS INC COM |  |  | 9 |
|  | &nbsp;&nbsp;LOEWS CORP COM |  |  | 552 |
|  | &nbsp;&nbsp;LOUISIANA-PACIFIC CORP COM |  |  | 158 |
|  | &nbsp;&nbsp;LUCID GROUP INC COM NEW |  |  | 42 |
|  | &nbsp;&nbsp;LULULEMON ATHLETICA INC COM |  |  | 283 |
|  | &nbsp;&nbsp;LUMENTUM HLDGS INC COM |  |  | 742 |
|  | &nbsp;&nbsp;LYFT INC CL A CL A |  |  | 193 |
|  | &nbsp;&nbsp;LYONDELLBASELL IND N V  |  |  | 343 |
|  | &nbsp;&nbsp;M & T BK CORP COM |  |  | 957 |
|  | &nbsp;&nbsp;MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC COM STK |  |  | 253 |
|  | &nbsp;&nbsp;MACYS INC COM STK |  |  | 181 |
|  | &nbsp;&nbsp;MADISON SQUARE GARDEN SPORTS CORP |  |  | 127 |
|  | &nbsp;&nbsp;MANPOWERGROUP INC |  |  | 42 |
|  | &nbsp;&nbsp;MAPLEBEAR INC COM |  |  | 239 |
|  | &nbsp;&nbsp;MARATHON PETE CORP COM |  |  | 1531 |
|  | &nbsp;&nbsp;MARKEL GROUP INC |  |  | 660 |
|  | &nbsp;&nbsp;MARKETAXESS HLDGS INC COM STK |  |  | 208 |
|  | &nbsp;&nbsp;MARTIN MARIETTA MATLS INC COM |  |  | 1155 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;MASCO CORP COM |  |  | 415 |
|  | &nbsp;&nbsp;MASTEC INC COM |  |  | 330 |
|  | &nbsp;&nbsp;MATADOR RES CO COM |  |  | 149 |
|  | &nbsp;&nbsp;MATCH GROUP INC NEW COM |  |  | 238 |
|  | &nbsp;&nbsp;MATTEL INC COM STOCK  |  |  | 190 |
|  | &nbsp;&nbsp;MC CORMICK & CO INC COM NON-VTG |  |  | 524 |
|  | &nbsp;&nbsp;MDU RES GROUP INC COM |  |  | 127 |
|  | &nbsp;&nbsp;METTLER-TOLEDO INTL INC COM |  |  | 888 |
|  | &nbsp;&nbsp;MGIC INVT CORP WIS COM |  |  | 198 |
|  | &nbsp;&nbsp;MGM RESORTS INTERNATIONAL COM |  |  | 231 |
|  | &nbsp;&nbsp;MICROCHIP TECHNOLOGY INC COM |  |  | 1041 |
|  | &nbsp;&nbsp;MIDDLEBY CORP COM |  |  | 233 |
|  | &nbsp;&nbsp;MILLICOM INTERNATIONAL CELLULAR COM  |  |  | 179 |
|  | &nbsp;&nbsp;MKS INC |  |  | 336 |
|  | &nbsp;&nbsp;MODERNA INC COM |  |  | 326 |
|  | &nbsp;&nbsp;MOHAWK INDS INC COM |  |  | 172 |
|  | &nbsp;&nbsp;MOLINA HEALTHCARE INC COM |  |  | 124 |
|  | &nbsp;&nbsp;MOLSON COORS BEVERAGE COMPANY COM  |  |  | 242 |
|  | &nbsp;&nbsp;MONGODB INC CL A CL A |  |  | 932 |
|  | &nbsp;&nbsp;MORNINGSTAR INC COM STK |  |  | 52 |
|  | &nbsp;&nbsp;MOSAIC CO/THE |  |  | 238 |
|  | &nbsp;&nbsp;MP MATERIALS CORP COM |  |  | 205 |
|  | &nbsp;&nbsp;MSA SAFETY INC COM |  |  | 178 |
|  | &nbsp;&nbsp;MSC INDL DIRECT INC CL A COM |  |  | 115 |
|  | &nbsp;&nbsp;MSCI INC COM |  |  | 660 |
|  | &nbsp;&nbsp;MUELLER INDS INC COM |  |  | 385 |
|  | &nbsp;&nbsp;NASDAQ INC |  |  | 1366 |
|  | &nbsp;&nbsp;NATL FUEL GAS CO COM |  |  | 222 |
|  | &nbsp;&nbsp;NCINO INC NEW COM |  |  | 74 |
|  | &nbsp;&nbsp;NETAPP INC COM STK |  |  | 398 |
|  | &nbsp;&nbsp;NEUROCRINE BIOSCIENCES INC COM |  |  | 61 |
|  | &nbsp;&nbsp;NEW YORK TIMES CO CL A  |  |  | 344 |
|  | &nbsp;&nbsp;NEWELL BRANDS INC COM |  |  | 48 |
|  | &nbsp;&nbsp;NEWMARKET CORP COM |  |  | 120 |
|  | &nbsp;&nbsp;NEWS CORP COM CL A |  |  | 304 |
|  | &nbsp;&nbsp;NEWS CORP COM CL B |  |  | 115 |
|  | &nbsp;&nbsp;NEXSTAR MEDIA GROUP INC COMMON STOCK |  |  | 165 |
|  | &nbsp;&nbsp;NIQ GLOBAL INTELLIGENCE PLC  |  |  | 12 |
|  | &nbsp;&nbsp;NISOURCE INC COM |  |  | 602 |
|  | &nbsp;&nbsp;NORDSON CORP COM |  |  | 394 |
| \* | &nbsp;&nbsp;NORTHERN TR CORP COM |  |  | 797 |
|  | &nbsp;&nbsp;NORWEGIAN CRUISE LINE HLDGS LTD COM |  |  | 30 |
|  | &nbsp;&nbsp;NOV INC COM |  |  | 170 |
|  | &nbsp;&nbsp;NUCOR CORP COM |  |  | 1154 |
|  | &nbsp;&nbsp;NUTANIX INC CL A CL A |  |  | 313 |
|  | &nbsp;&nbsp;NVENT ELECTRIC PLC COM  |  |  | 503 |
|  | &nbsp;&nbsp;NVR INC COM STK |  |  | 613 |
|  | &nbsp;&nbsp;OCCIDENTAL PETROLEUM CORP |  |  | 895 |
|  | &nbsp;&nbsp;OGE ENERGY CORP COM |  |  | 267 |
|  | &nbsp;&nbsp;OKTA INC CL A CL A |  |  | 271 |
|  | &nbsp;&nbsp;OLD DOMINION FREIGHT LINE INC COM |  |  | 841 |
|  | &nbsp;&nbsp;OLD REPUBLIC INTERNATIONAL CORP COM |  |  | 321 |
|  | &nbsp;&nbsp;OLIN CORP COM |  |  | 74 |
|  | &nbsp;&nbsp;OLLIES BARGAIN OUTLET HLDGS INC COM |  |  | 207 |
|  | &nbsp;&nbsp;OMNICOM GROUP INC COM |  |  | 799 |
|  | &nbsp;&nbsp;ON SEMICONDUCTOR CORP COM |  |  | 684 |
|  | &nbsp;&nbsp;ONEMAIN HLDGS INC COM |  |  | 254 |
|  | &nbsp;&nbsp;ONEOK INC COM STK |  |  | 1422 |
|  | &nbsp;&nbsp;ONTO INNOVATION INC |  |  | 184 |
|  | &nbsp;&nbsp;ORD SHS |  |  | 32 |
|  | &nbsp;&nbsp;ORGANON & CO COM |  |  | 58 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;OSHKOSH CORPORATION |  |  | 251 |
|  | &nbsp;&nbsp;OTIS WORLDWIDE CORP COM  |  |  | 1056 |
|  | &nbsp;&nbsp;OVINTIV INC COM  |  |  | 308 |
|  | &nbsp;&nbsp;OWENS CORNING NEW COM STK |  |  | 286 |
|  | &nbsp;&nbsp;PACKAGING CORP AMER COM |  |  | 564 |
|  | &nbsp;&nbsp;PARSONS CORP DEL COM |  |  | 102 |
|  | &nbsp;&nbsp;PAYCHEX INC COM |  |  | 762 |
|  | &nbsp;&nbsp;PAYCOM SOFTWARE INC COM |  |  | 115 |
|  | &nbsp;&nbsp;PAYLOCITY HLDG CORP COM |  |  | 16 |
|  | &nbsp;&nbsp;PEGASYSTEMS INC COM |  |  | 108 |
|  | &nbsp;&nbsp;PENN ENTERTAINMENT INC |  |  | 66 |
|  | &nbsp;&nbsp;PENSKE AUTOMOTIVE GROUP INC COM STK |  |  | 87 |
|  | &nbsp;&nbsp;PENTAIR PLC COM  |  |  | 519 |
|  | &nbsp;&nbsp;PERFORMANCE FOOD GROUP CO COM |  |  | 370 |
|  | &nbsp;&nbsp;PERMIAN RES CORP CL A |  |  | 308 |
|  | &nbsp;&nbsp;PERRIGO COMPANY LIMITED COM |  |  | 57 |
|  | &nbsp;&nbsp;PG& E CORP COM |  |  | 1090 |
|  | &nbsp;&nbsp;PHILLIPS 66 COM |  |  | 1494 |
|  | &nbsp;&nbsp;PILGRIMS PRIDE CORP |  |  | 50 |
|  | &nbsp;&nbsp;PINNACLE  |  |  | 209 |
|  | &nbsp;&nbsp;PINNACLE W. CAP CORP COM |  |  | 329 |
|  | &nbsp;&nbsp;PINTEREST INC CL A CL A |  |  | 238 |
|  | &nbsp;&nbsp;POOL CORP COM STK |  |  | 189 |
|  | &nbsp;&nbsp;POPULAR INC COM NEW COM  |  |  | 234 |
|  | &nbsp;&nbsp;POST HLDGS INC COM STK |  |  | 149 |
|  | &nbsp;&nbsp;PPG IND INC COM |  |  | 713 |
|  | &nbsp;&nbsp;PPL CORP COM  |  |  | 800 |
|  | &nbsp;&nbsp;PRIMERICA INC COM |  |  | 257 |
|  | &nbsp;&nbsp;PRIMO BRANDS CORPORATION COM  |  |  | 130 |
|  | &nbsp;&nbsp;PRINCIPAL FINL GROUP INC COM STK |  |  | 592 |
|  | &nbsp;&nbsp;PROSPERITY BANCSHARES INC COM |  |  | 194 |
|  | &nbsp;&nbsp;PRUDENTIAL FINL INC COM |  |  | 1221 |
|  | &nbsp;&nbsp;PTC INC COM |  |  | 568 |
|  | &nbsp;&nbsp;PUB SERVICE ENTERPRISE GROUP INC COM |  |  | 1242 |
|  | &nbsp;&nbsp;PULTE GROUP INC |  |  | 698 |
|  | &nbsp;&nbsp;PURE STORAGE INC CL A CL A |  |  | 94 |
|  | &nbsp;&nbsp;PVH CORP COM  |  |  | 99 |
|  | &nbsp;&nbsp;QIAGEN  |  |  | 300 |
|  | &nbsp;&nbsp;QNITY ELECTRONICS INC COM |  |  | 529 |
|  | &nbsp;&nbsp;QORVO INC COM |  |  | 220 |
|  | &nbsp;&nbsp;QUANTA SVCS INC COM |  |  | 433 |
|  | &nbsp;&nbsp;QUANTUMSCAPE CORP  |  |  | 145 |
|  | &nbsp;&nbsp;QUEST DIAGNOSTICS INC COM |  |  | 600 |
|  | &nbsp;&nbsp;QXO INC COM PAR VALUE |  |  | 367 |
|  | &nbsp;&nbsp;RALLIANT CORP COM  |  |  | 177 |
|  | &nbsp;&nbsp;RALPH LAUREN CORP CL A CL A |  |  | 378 |
|  | &nbsp;&nbsp;RANGE RES CORP COM |  |  | 256 |
|  | &nbsp;&nbsp;RAYMOND JAMES FNCL INC COM STK |  |  | 889 |
|  | &nbsp;&nbsp;RB GLOBAL INC COM NPV |  |  | 542 |
|  | &nbsp;&nbsp;RBC BEARINGS INC COM |  |  | 343 |
|  | &nbsp;&nbsp;REGAL REXNORD CORPORATION COM STK  |  |  | 286 |
|  | &nbsp;&nbsp;REGIONS FINL CORP NEW COM |  |  | 751 |
|  | &nbsp;&nbsp;REINSURANCE GROUP AMER INC COM NEW STK |  |  | 414 |
|  | &nbsp;&nbsp;RELIANCE INC COM NPV |  |  | 462 |
|  | &nbsp;&nbsp;RENAISSANCE RE HLDGS LTD COM |  |  | 393 |
|  | &nbsp;&nbsp;REPLIGEN CORP COM STK  |  |  | 234 |
|  | &nbsp;&nbsp;RESMED INC COM |  |  | 822 |
|  | &nbsp;&nbsp;RESTAURANT BRANDS INTL INC COM NPV |  |  | 248 |
|  | &nbsp;&nbsp;REVOLUTION MEDICINES INC COM |  |  | 426 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;REVVITY INC |  |  | 354 |
|  | &nbsp;&nbsp;REYNOLDS CONSUMER PRODS INC COM |  |  | 38 |
|  | &nbsp;&nbsp;RH COM |  |  | 71 |
|  | &nbsp;&nbsp;RIVIAN AUTOMOTIVE INC |  |  | 479 |
|  | &nbsp;&nbsp;RLI CORP COM |  |  | 152 |
|  | &nbsp;&nbsp;ROBERT HALF INC COM  |  |  | 82 |
|  | &nbsp;&nbsp;ROBINHOOD MKTS INC COM CL A COM CL A |  |  | 2244 |
|  | &nbsp;&nbsp;ROCKET COS INC CL A CL A |  |  | 564 |
|  | &nbsp;&nbsp;ROCKWELL AUTOMATION |  |  | 1247 |
|  | &nbsp;&nbsp;ROIVANT SCIENCES LTD COM  |  |  | 259 |
|  | &nbsp;&nbsp;ROKU INC COM CL A COM CL A |  |  | 375 |
|  | &nbsp;&nbsp;ROSS STORES INC COM |  |  | 1427 |
|  | &nbsp;&nbsp;ROYAL GOLD INC COM STK  |  |  | 563 |
|  | &nbsp;&nbsp;ROYALTY PHARMA PLC COM |  |  | 465 |
|  | &nbsp;&nbsp;RPM INTL INC |  |  | 404 |
|  | &nbsp;&nbsp;RUBRIK INC COM  |  |  | 127 |
|  | &nbsp;&nbsp;RYDER SYS INC COM |  |  | 231 |
|  | &nbsp;&nbsp;S.W. AIRL CO COM |  |  | 530 |
|  | &nbsp;&nbsp;SAIA INC COM STK |  |  | 268 |
|  | &nbsp;&nbsp;SAILPOINT INC COM |  |  | 37 |
|  | &nbsp;&nbsp;SANDISK CORP COM |  |  | 993 |
|  | &nbsp;&nbsp;SAREPTA THERAPEUTICS INC COM |  |  | 10 |
|  | &nbsp;&nbsp;SCHNEIDER NATL INC WIS CL B CL B |  |  | 42 |
|  | &nbsp;&nbsp;SCIENCE APPLICATIONS INTL CORP NEW COM  |  |  | 142 |
|  | &nbsp;&nbsp;SCOTTS MIRACLE-GRO CLASS'A'COM NPV |  |  | 79 |
|  | &nbsp;&nbsp;SEABOARD CORP DEL COM |  |  | 36 |
|  | &nbsp;&nbsp;SEALED AIR CORP NEW COM STK |  |  | 187 |
|  | &nbsp;&nbsp;SEI INVTS CO COM |  |  | 264 |
|  | &nbsp;&nbsp;SENSATA TECHNOLOGIES B V HOLDING |  |  | 148 |
|  | &nbsp;&nbsp;SENTINELONE INC CL A COM CL A COM |  |  | 38 |
|  | &nbsp;&nbsp;SERVICE CORP INTL COM |  |  | 339 |
|  | &nbsp;&nbsp;SHARKNINJA COM  |  |  | 239 |
|  | &nbsp;&nbsp;SILGAN HLDGS INC COM |  |  | 112 |
|  | &nbsp;&nbsp;SIMPSON MFG INC COM |  |  | 194 |
|  | &nbsp;&nbsp;SIRIUS XM HLDGS INC NEW COM |  |  | 117 |
|  | &nbsp;&nbsp;SITEONE LANDSCAPE SUPPLY INC COM |  |  | 115 |
|  | &nbsp;&nbsp;SKYWORKS SOLUTIONS INC COM |  |  | 291 |
|  | &nbsp;&nbsp;SLM CORP COM |  |  | 153 |
|  | &nbsp;&nbsp;SM ENERGY CO |  |  | 78 |
|  | &nbsp;&nbsp;SMITH A O CORP COM |  |  | 235 |
|  | &nbsp;&nbsp;SMITHFIELD FOODS INC COM |  |  | 31 |
|  | &nbsp;&nbsp;SMUCKER J M CO COM NEW |  |  | 315 |
|  | &nbsp;&nbsp;SMURFIT WESTROCK LTD |  |  | 623 |
|  | &nbsp;&nbsp;SNAP-ON INC COM |  |  | 546 |
|  | &nbsp;&nbsp;SOFI TECHNOLOGIES INC COM |  |  | 849 |
|  | &nbsp;&nbsp;SOLVENTUM CORP COM COM  |  |  | 363 |
|  | &nbsp;&nbsp;SONOCO PROD CO COM |  |  | 134 |
|  | &nbsp;&nbsp;SOTERA HEALTH CO COM |  |  | 101 |
|  | &nbsp;&nbsp;SOUTHSTATE BK CORP COM |  |  | 292 |
|  | &nbsp;&nbsp;SS&C TECHNOLOGIES HLDGS INC COM |  |  | 566 |
|  | &nbsp;&nbsp;STANDARDAERO INC. COM  |  |  | 116 |
|  | &nbsp;&nbsp;STANLEY BLACK & DECKER INC COM |  |  | 356 |
|  | &nbsp;&nbsp;STATE STR CORP COM |  |  | 1116 |
|  | &nbsp;&nbsp;STEEL DYNAMICS INC COM |  |  | 664 |
|  | &nbsp;&nbsp;STERIS PLC ORD |  |  | 771 |
|  | &nbsp;&nbsp;STIFEL FINL CORP COM |  |  | 392 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;SUPER MICRO COMPUTER INC COM NEW |  |  | 252 |
|  | &nbsp;&nbsp;SYNCHRONY FINL COM |  |  | 929 |
|  | &nbsp;&nbsp;SYNOVUS  |  |  | 213 |
|  | &nbsp;&nbsp;SYSCO CORP COM |  |  | 506 |
|  | &nbsp;&nbsp;T ROWE PRICE GROUP INC |  |  | 689 |
|  | &nbsp;&nbsp;TAKE-TWO INTERACTIVE SOFTWARE INC COM STK |  |  | 942 |
|  | &nbsp;&nbsp;TALEN ENERGY CORP NEW COM |  |  | 527 |
|  | &nbsp;&nbsp;TAPESTRY INC COM |  |  | 67 |
|  | &nbsp;&nbsp;TD SYNNEX CORPORATION COM  |  |  | 353 |
|  | &nbsp;&nbsp;TECHNIPFMC PLC COM USD1 |  |  | 550 |
|  | &nbsp;&nbsp;TELEDYNE TECHNOLOGIES INC COM |  |  | 731 |
|  | &nbsp;&nbsp;TELEFLEX INC COM |  |  | 167 |
|  | &nbsp;&nbsp;TENET HEALTHCARE CORP COM NEW. |  |  | 536 |
|  | &nbsp;&nbsp;TERADATA CORP DEL COM STK |  |  | 68 |
|  | &nbsp;&nbsp;TERADYNE INC COM |  |  | 938 |
|  | &nbsp;&nbsp;TETRA TECH INC NEW COM |  |  | 221 |
|  | &nbsp;&nbsp;TEXTRON INC COM |  |  | 476 |
|  | &nbsp;&nbsp;TFS FINL CORP COM STK |  |  | 24 |
|  | &nbsp;&nbsp;THE CAMPBELLS COMPANY |  |  | 168 |
|  | &nbsp;&nbsp;THE COOPER COMPANIES, INC. |  |  | 498 |
|  | &nbsp;&nbsp;THE HARTFORD INSURANCE GROUP INC COM  |  |  | 1197 |
|  | &nbsp;&nbsp;THOR INDS INC COM STK |  |  | 160 |
|  | &nbsp;&nbsp;TIMKEN CO COM |  |  | 162 |
|  | &nbsp;&nbsp;TKO GROUP HLDGS INC COM |  |  | 255 |
|  | &nbsp;&nbsp;TOLL BROS INC COM |  |  | 402 |
|  | &nbsp;&nbsp;TOPBUILD CORP COM |  |  | 337 |
|  | &nbsp;&nbsp;TORO CO COM |  |  | 239 |
|  | &nbsp;&nbsp;TPG PARTNERS LLC CL A COM |  |  | 19 |
|  | &nbsp;&nbsp;TRADEWEB MKTS INC CL A CL A |  |  | 359 |
|  | &nbsp;&nbsp;TRANSUNION COM |  |  | 517 |
|  | &nbsp;&nbsp;TRAVEL + LEISURE CO COM  |  |  | 90 |
|  | &nbsp;&nbsp;TREX CO INC COM |  |  | 117 |
|  | &nbsp;&nbsp;TRIMBLE INC COM TRIMBLE INC |  |  | 577 |
|  | &nbsp;&nbsp;TRUMP MEDIA & TECHNOLOGY GROUP CORP |  |  | 31 |
|  | &nbsp;&nbsp;TWILIO INC CL A CL A |  |  | 519 |
|  | &nbsp;&nbsp;TYLER TECHNOLOGIES INC COM STK |  |  | 103 |
|  | &nbsp;&nbsp;TYSON FOODS INC CL A COM (DELAWARE) |  |  | 506 |
|  | &nbsp;&nbsp;UGI CORP NEW COM |  |  | 249 |
|  | &nbsp;&nbsp;U-HAUL HOLDING COMPANY |  |  | 88 |
|  | &nbsp;&nbsp;U-HAUL HOLDING COMPANY |  |  | 9 |
|  | &nbsp;&nbsp;UIPATH INC CL A CL A |  |  | 204 |
|  | &nbsp;&nbsp;ULTA BEAUTY INC  |  |  | 634 |
|  | &nbsp;&nbsp;UNDER ARMOR INC CL A |  |  | 29 |
|  | &nbsp;&nbsp;UNDER ARMOUR INC CL C COM |  |  | 29 |
|  | &nbsp;&nbsp;UNITED AIRLINES HOLDINGS INC COM  |  |  | 1121 |
|  | &nbsp;&nbsp;UNITED RENTALS INC COM |  |  | 1590 |
|  | &nbsp;&nbsp;UNITED THERAPEUTICS CORP DEL COM STK |  |  | 639 |
|  | &nbsp;&nbsp;UNITY SOFTWARE INC COM |  |  | 414 |
|  | &nbsp;&nbsp;UNIVERSAL DISPLAY CORP COM |  |  | 159 |
|  | &nbsp;&nbsp;UNUM GROUP |  |  | 405 |
|  | &nbsp;&nbsp;UNVL HEALTH SERVICES INC CL B COM |  |  | 362 |
|  | &nbsp;&nbsp;US FOODS HLDG CORP COM |  |  | 536 |
|  | &nbsp;&nbsp;UWM HLDGS CORP COM  |  |  | 21 |
|  | &nbsp;&nbsp;V F CORP COM |  |  | 196 |
|  | &nbsp;&nbsp;VAIL RESORTS INC COM |  |  | 26 |
|  | &nbsp;&nbsp;VALERO ENERGY CORP COM STK NEW |  |  | 1531 |
|  | &nbsp;&nbsp;VALMONT INDS INC COM |  |  | 241 |
|  | &nbsp;&nbsp;VALVOLINE INC COM |  |  | 13 |
|  | &nbsp;&nbsp;VEEVA SYS INC CL A COM CL A COM |  |  | 205 |
|  | &nbsp;&nbsp;VERALTO CORP COM |  |  | 446 |
|  | &nbsp;&nbsp;VERISIGN INC COM |  |  | 627 |
|  | &nbsp;&nbsp;VERISK ANALYTICS INC COM  |  |  | 389 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp; <br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp; <br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp; <br>**(e) Current**<br>**value** |
|  | **Common stock - continued** |  |  |  |
|  | &nbsp;&nbsp;VIATRIS INC |  |  | 444 |
|  | &nbsp;&nbsp;VIKING THERAPEUTICS INC COM |  |  | 112 |
|  | &nbsp;&nbsp;VIPER ENERGY INC NEW CL A |  |  | 203 |
|  | &nbsp;&nbsp;VIRTU FINL INC CL A CL A |  |  | 84 |
|  | &nbsp;&nbsp;VONTIER CORP COM |  |  | 167 |
|  | &nbsp;&nbsp;VOYA FINL INC COM |  |  | 226 |
|  | &nbsp;&nbsp;VULCAN MATERIALS CO COM |  |  | 1167 |
|  | &nbsp;&nbsp;WABTEC CORP COM |  |  | 1120 |
|  | &nbsp;&nbsp;WARNER BROS DISCOVERY INC |  |  | 2077 |
|  | &nbsp;&nbsp;WATERS CORP COM |  |  | 334 |
|  | &nbsp;&nbsp;WATSCO INC COM |  |  | 362 |
|  | &nbsp;&nbsp;WAYFAIR INC CL A CL A |  |  | 239 |
|  | &nbsp;&nbsp;WEATHERFORD INTL LTD COMMON STOCK |  |  | 174 |
|  | &nbsp;&nbsp;WEBSTER FNCL CORP WATERBURY CONN COM |  |  | 318 |
|  | &nbsp;&nbsp;WEC ENERGY GROUP INC COM |  |  | 1069 |
|  | &nbsp;&nbsp;WENDYS CO COM |  |  | 23 |
|  | &nbsp;&nbsp;WESCO INTL INC COM |  |  | 362 |
|  | &nbsp;&nbsp;WEST PHARMACEUTICAL SVCS INC COM |  |  | 613 |
|  | &nbsp;&nbsp;WESTERN ALLIANCE BANCORPORATION COM |  |  | 221 |
|  | &nbsp;&nbsp;WESTERN UNION CO |  |  | 98 |
|  | &nbsp;&nbsp;WESTLAKE CORPORATION COM |  |  | 80 |
|  | &nbsp;&nbsp;WESTN DIGITAL CORP COM |  |  | 1836 |
|  | &nbsp;&nbsp;WEX INC COM |  |  | 146 |
|  | &nbsp;&nbsp;WHIRLPOOL CORP COM |  |  | 121 |
|  | &nbsp;&nbsp;WHITE MOUNTAINS INSURANCE GROUP |  |  | 158 |
|  | &nbsp;&nbsp;WILLIAMS SONOMA INC COM |  |  | 557 |
|  | &nbsp;&nbsp;WILLIS TOWERS WATSON PLC |  |  | 991 |
|  | &nbsp;&nbsp;WILLSCOT HOLDINGS CORPORATION COM |  |  | 77 |
|  | &nbsp;&nbsp;WINTRUST FINL CORP COM |  |  | 284 |
|  | &nbsp;&nbsp;WOODWARD INC COM |  |  | 561 |
|  | &nbsp;&nbsp;WYNDHAM HOTELS & RESORTS INC COM |  |  | 20 |
|  | &nbsp;&nbsp;WYNN RESORTS LTD COM |  |  | 285 |
|  | &nbsp;&nbsp;XCEL ENERGY INC COM |  |  | 1355 |
|  | &nbsp;&nbsp;XP INC COM CLASS A |  |  | 183 |
|  | &nbsp;&nbsp;XPO INC COM |  |  | 382 |
|  | &nbsp;&nbsp;XYLEM INC COM |  |  | 1019 |
|  | &nbsp;&nbsp;YETI HLDGS INC COM |  |  | 110 |
|  | &nbsp;&nbsp;YUM BRANDS INC COM |  |  | 868 |
|  | &nbsp;&nbsp;ZEBRA TECHNOLOGIES CORP CL A |  |  | 382 |
|  | &nbsp;&nbsp;ZILLOW GROUP INC COM |  |  | 105 |
|  | &nbsp;&nbsp;ZILLOW GROUP INC COM CLASS C |  |  | 344 |
|  | &nbsp;&nbsp;ZIMMER BIOMET HLDGS INC COM |  |  | 552 |
|  | &nbsp;&nbsp;ZIONS BANCORPORATION N A |  |  | 259 |
|  | &nbsp;&nbsp;ZOOM COMMUNICATIONS INC |  |  | 711 |
|  | &nbsp;&nbsp;ZOOMINFO TECHNOLOGIES INC COM |  |  | 83 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Common stock |  |  | 5585157 |
|  | **Mutual fund** |  |  |  |
|  | &nbsp;&nbsp;PIMCO ALL ASSET FUND |  |  | 120058 |
|  | **REITs** |  |  |  |
|  | &nbsp;&nbsp;1ST INDL RLTY TR INC COM |  |  | 226 |
|  | &nbsp;&nbsp;AGNC INVT CORP COM |  |  | 333 |
|  | &nbsp;&nbsp;AGREE RLTY CORP COM |  |  | 242 |
|  | &nbsp;&nbsp;ALEXANDRIA REAL ESTATE EQUITIES INC COM |  |  | 259 |
|  | &nbsp;&nbsp;AMERICAN HOMES 4 RENT COMMON STOCK |  |  | 339 |
|  | &nbsp;&nbsp;AMERICOLD RLTY TR INC COM |  |  | 113 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **REITs - continued** |  |  |  |
|  | &nbsp;&nbsp;ANNALY CAPITAL MANAGEMENT INC COM |  |  | 487 |
|  | &nbsp;&nbsp;AVALONBAY CMNTYS REIT |  |  | 798 |
|  | &nbsp;&nbsp;BRIXMOR PPTY GROUP INC COM |  |  | 249 |
|  | &nbsp;&nbsp;BXP INC |  |  | 332 |
|  | &nbsp;&nbsp;CAMDEN PPTY TR SH BEN INT |  |  | 367 |
|  | &nbsp;&nbsp;COUSINS PPTYS INC |  |  | 133 |
|  | &nbsp;&nbsp;CROWN CASTLE INC COM |  |  | 1194 |
|  | &nbsp;&nbsp;CUBESMART |  |  | 254 |
|  | &nbsp;&nbsp;DIGITAL RLTY TR INC COM |  |  | 1648 |
|  | &nbsp;&nbsp;EASTGROUP PPTYS INC REIT |  |  | 290 |
|  | &nbsp;&nbsp;EPR PPTYS COM SH BEN INT COM SH BEN INT |  |  | 117 |
|  | &nbsp;&nbsp;EQTY LIFESTYLE PPTYS INC REIT |  |  | 361 |
|  | &nbsp;&nbsp;EQTY RESDNTL EFF 5/15/02 |  |  | 738 |
|  | &nbsp;&nbsp;ESSEX PPTY TR REIT |  |  | 511 |
|  | &nbsp;&nbsp;EXTRA SPACE STORAGE INC COM |  |  | 850 |
|  | &nbsp;&nbsp;FEDERAL RLTY INVT TR COM USD0.01 |  |  | 260 |
|  | &nbsp;&nbsp;GAMING & LEISURE PPTYS INC COM |  |  | 374 |
|  | &nbsp;&nbsp;HEALTHCARE REALTY TRUST INC |  |  | 173 |
|  | &nbsp;&nbsp;HEALTHPEAK OP LLC |  |  | 346 |
|  | &nbsp;&nbsp;HIGHWOODS PPTYS INC COM |  |  | 84 |
|  | &nbsp;&nbsp;HOST HOTELS & RESORTS INC REIT |  |  | 376 |
|  | &nbsp;&nbsp;INVITATION HOMES INC COM |  |  | 527 |
|  | &nbsp;&nbsp;IRON MTN INC NEW COM |  |  | 754 |
|  | &nbsp;&nbsp;KILROY RLTY CORP COM |  |  | 134 |
|  | &nbsp;&nbsp;KIMCO REALTY CORPORATION |  |  | 416 |
|  | &nbsp;&nbsp;LINEAGE INC COM |  |  | 78 |
|  | &nbsp;&nbsp;MEDICAL PPTYS TR INC COM REIT |  |  | 77 |
|  | &nbsp;&nbsp;MID-AMER APT CMNTYS INC COM |  |  | 500 |
|  | &nbsp;&nbsp;MILLROSE PROPERTIES INC. COM |  |  | 141 |
|  | &nbsp;&nbsp;NATIONAL STORAGE AFFILIATES TR COM SHS |  |  | 62 |
|  | &nbsp;&nbsp;NNN REIT INC |  |  | 231 |
|  | &nbsp;&nbsp;OMEGA HEALTHCARE INVS INC REIT |  |  | 406 |
|  | &nbsp;&nbsp;PARK HOTELS & RESORTS INC COM |  |  | 62 |
|  | &nbsp;&nbsp;RAYONIER INC REIT |  |  | 106 |
|  | &nbsp;&nbsp;REALTY INCOME CORP COM |  |  | 1601 |
|  | &nbsp;&nbsp;REGENCY CTRS CORP COM |  |  | 385 |
|  | &nbsp;&nbsp;REXFORD INDL RLTY INC COM |  |  | 280 |
|  | &nbsp;&nbsp;RITHM CAPITAL CORP |  |  | 190 |
|  | &nbsp;&nbsp;SBA COMMUNICATIONS CORP |  |  | 644 |
|  | &nbsp;&nbsp;SIMON PROPERTY GROUP INC COM |  |  | 1441 |
|  | &nbsp;&nbsp;STAG INDL INC COM |  |  | 212 |
|  | &nbsp;&nbsp;STARWOOD PROPERTY TRUST INC COM REIT |  |  | 196 |
|  | &nbsp;&nbsp;SUN COMMUNITIES INC COM |  |  | 393 |
|  | &nbsp;&nbsp;UDR INC COM STK |  |  | 355 |
|  | &nbsp;&nbsp;VENTAS INC REIT |  |  | 1121 |
|  | &nbsp;&nbsp;VICI PPTYS INC COM |  |  | 934 |
|  | &nbsp;&nbsp;VORNADO RLTY TR COM |  |  | 182 |
|  | &nbsp;&nbsp;W P CAREY INC COM |  |  | 434 |
|  | &nbsp;&nbsp;WEYERHAEUSER CO COM |  |  | 530 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total REITs |  |  | 23846 |
|  | **Collective trust funds** |  |  |  |
|  | &nbsp;&nbsp;BLACKROCK INTERNATIONAL MULTI CAP EQUITY FUND |  |  | 116749 |
|  | &nbsp;&nbsp;CAPITAL GROUP EUPAC TRUST |  |  | 442716 |
|  | &nbsp;&nbsp;CAPITAL GROUP GROWTH FUND OF AMERICA TRUST |  |  | 1506310 |
|  | &nbsp;&nbsp;CAPITAL GROUP WASHINGTON MUTUAL INVESTORS TRUST |  |  | 441434 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp; <br>**(e) Current**<br>**value** |
|  | **Collective trust funds - continued** |  |  |  |
|  | &nbsp;&nbsp;GW&K SMALL-MID CAP CORE EQUITY FUND |  |  | 159818 |
| \* | &nbsp;&nbsp;NORTHERN TRUST COLLECTIVE MSCI ACWI EX-US INDEX FUND |  |  | 229531 |
| \* | &nbsp;&nbsp;NORTHERN TRUST COLLECTIVE SHORT TERM INVESTMENT FUND |  |  | 17255 |
|  | &nbsp;&nbsp;PIMCO TOTAL RETURN |  |  | 229481 |
|  | &nbsp;&nbsp;SSGA RUSSELL SMALL/MID CAP INDEX |  |  | 910059 |
|  | &nbsp;&nbsp;SSGA S&P 500 INDEX  |  |  | 2622633 |
|  | &nbsp;&nbsp;SSGA US BOND INDEX  |  |  | 186789 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2025 |  |  | 416322 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2030 |  |  | 654000 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2035 |  |  | 681640 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2040  |  |  | 598322 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2045 |  |  | 536656 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2050 |  |  | 455296 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2055 |  |  | 317868 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2060 |  |  | 189986 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2065 |  |  | 68655 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT 2070 |  |  | 5058 |
|  | &nbsp;&nbsp;SSGA TARGET RETIREMENT INCOME |  |  | 334095 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Collective trust funds |  |  | 11120673 |
|  | **Futures contracts** |  |  |  |
|  | &nbsp;&nbsp;FUT MAR 26 IMMEMINI MDCP |  |  | 997560 |
|  | &nbsp;&nbsp;FUT MAR 26 IMMEMINI MDCP |  |  | (997560) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Futures contracts |  |  |  |
|  | **Corporate debt** |  |  |  |
|  | &nbsp;&nbsp;AMERICAN HONDA FIN CORP MED TERM NTS BOOVAR RT DUE 03-08-2027 |  |  | 5112 |
|  | &nbsp;&nbsp;AMERICAN TOWER CORP NEW 1.6% DUE 04-15-2026 BEO |  |  | 2796 |
|  | &nbsp;&nbsp;AMERN HONDA FIN FLTG RT 4.400447% DUE 08-13-2027 |  |  | 2004 |
|  | &nbsp;&nbsp;AMERN TOWER CORP 4.4% DUE 02-15-2026 |  |  | 253 |
|  | &nbsp;&nbsp;AVOLON HLDGS FDG 2.125% DUE 02-21-2026 |  |  | 240 |
|  | &nbsp;&nbsp;B A T INTL FIN PLC FIXED 1.668% DUE 03-25-2026 |  |  | 398 |
|  | &nbsp;&nbsp;BAIN CAP CR CLO FLTG RT 0% DUE 04-23-2035 |  |  | 999 |
|  | &nbsp;&nbsp;BANK OF AMERICA CORP 1.734% 07-22-2027 |  |  | 2468 |
|  | &nbsp;&nbsp;BARCLAYS PLC 4.375% DUE 01-12-2026 |  |  | 4800 |
|  | &nbsp;&nbsp;BARCLAYS PLC FLTG 09-13-2027 |  |  | 2018 |
|  | &nbsp;&nbsp;BERRY GLOBAL INC 1.57% DUE 01-15-2026 |  |  | 1898 |
|  | &nbsp;&nbsp;BOEING CO 2.25% DUE 06-15-2026 |  |  | 396 |
|  | &nbsp;&nbsp;BOEING CO FIXED 2.196% DUE 02-04-2026 |  |  | 9183 |
|  | &nbsp;&nbsp;CANYON CLO 2021-4 FLTG RT 5.10331% DUE 10-15-2034 |  |  | 1999 |
|  | &nbsp;&nbsp;CARMAX AUTO OWNER FLTG RT 4.34819% DUE 07-17-2028 |  |  | 5173 |
|  | &nbsp;&nbsp;CARMAX AUTO OWNER TRUST SER 22-4 CL A3 5.34% DUE 08-16-2027 REG |  |  | 602 |
|  | &nbsp;&nbsp;CGI INC 1.45% 09-14-2026 |  |  | 3189 |
|  | &nbsp;&nbsp;CHASE AUTO OWNER TR 2024-5 NT CL A-2 144A 4.4% 11-26-2027 |  |  | 260 |
|  | &nbsp;&nbsp;CROWN CASTLE INTL 3.7% DUE 06-15-2026 |  |  | 4989 |
|  | &nbsp;&nbsp;DELL INTL L L C/EMC CORP 4.9% 10-01-2026 |  |  | 1105 |
|  | &nbsp;&nbsp;DLLAD 2024-1 LLC 5.5% DUE 08-20-2027 |  |  | 757 |
|  | &nbsp;&nbsp;ELEVATION CLO FLTG RT 0% DUE 07-25-2034 |  |  | 1499 |
|  | &nbsp;&nbsp;ELLINGTON FINL MTG TR 2022-1 MTG PASS THRU CTF CL A-1 2.206% 01-25-2067 |  |  | 1846 |
|  | &nbsp;&nbsp;EMERA US FIN LP 3.55% DUE 06-15-2026 |  |  | 299 |
|  | &nbsp;&nbsp;EXPORT DEV CDA FLTG RT 08-01-2028 |  |  | 3006 |
|  | &nbsp;&nbsp;FORD CR AUTO LEASE TR 2024-B SR 24-B CL A2B FLTG RT 02-15-2027 |  |  | 337 |
|  | &nbsp;&nbsp;FORD CR AUTO OWNER 5.4% DUE 04-15-2027 |  |  | 743 |
|  | &nbsp;&nbsp;FORD MOTOR CREDIT CO LLC 5.8% 03-05-2027 |  |  | 2835 |
|  | &nbsp;&nbsp;FORD MTR CR CO LLC 5.125% 11-05-2026 |  |  | 2916 |
|  | &nbsp;&nbsp;GM FINL AUTOMOBILE LEASING TR SR 25-1 A2B FLTG RT 05-20-2027 |  |  | 290 |
|  | &nbsp;&nbsp;GOLDMAN SACHS BANK USA FLTG RT 03-18-2027 |  |  | 2903 |
|  | &nbsp;&nbsp;GOLDMAN SACHS GROUP INC DUE 03-09-2027/03-09-2026 REG |  |  | 1401 |
|  | &nbsp;&nbsp;GS MTG BACKED SECS 4.54728% DUE 01-25-2052 |  |  | 2159 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | <br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Corporate debt - continued** |  |  |  |
|  | &nbsp;&nbsp;HCA INC 5.25% DUE 06-15-2026 |  |  | 1201 |
|  | &nbsp;&nbsp;HCA INC 5.375% DUE 09-01-2026 |  |  | 1002 |
|  | &nbsp;&nbsp;HYUNDAI AUTO LEASE FLTG RT 4.04819% DUE 01-18-2028 |  |  | 2500 |
|  | &nbsp;&nbsp;HYUNDAI CAP AMER VAR RT 4.727649% DUE 03-19-2027 |  |  | 2639 |
|  | &nbsp;&nbsp;HYUNDAI CAP AMER VAR RT 5.164638% DUE 01-08-2027 |  |  | 1381 |
|  | &nbsp;&nbsp;LLOYDS BANKING GROUP PLC 5.985% 08-07-2027 |  |  | 3337 |
|  | &nbsp;&nbsp;MERCEDES-BENZ AUTO LEASE TRUST SR 24-B CL A2B FLTG RT 12-15-2026 |  |  | 394 |
|  | &nbsp;&nbsp;MFA 2020-NQM2 TR 1.381% DUE 04-25-2065 |  |  | 160 |
|  | &nbsp;&nbsp;MORGAN STANLEY 5.05% DUE 01-28-2027 |  |  | 3002 |
|  | &nbsp;&nbsp;MORGAN STANLEY BANK FRN 10-15-2027 |  |  | 6012 |
|  | &nbsp;&nbsp;NATWEST GROUP PLC 5.847% DUE 03-02-2027 |  |  | 2005 |
|  | &nbsp;&nbsp;NAVESINK CLO 2 LTD / NAVESINK CLO 2 4.86219% 01-15-2036 |  |  | 900 |
|  | &nbsp;&nbsp;NAVIENT PRIVATE ED LN TR 2020-I 4.77413%04-15-2069 |  |  | 921 |
|  | &nbsp;&nbsp;NOMURA HOLDINGS INC 5.709% 01-09-2026 |  |  | 4801 |
|  | &nbsp;&nbsp;OBX 2022-NQM1 TR MTG BACKED NT CL A-1 144A 2.305% 11-25-2061 |  |  | 1698 |
|  | &nbsp;&nbsp;OBX 2022-NQM2 TR 2.783% DUE 01-25-2062 |  |  | 552 |
|  | &nbsp;&nbsp;ONEOK INC 4.25% 09-24-2027 |  |  | 1204 |
|  | &nbsp;&nbsp;PAC GAS & ELEC CO FIXED 2.95% DUE 03-01-2026 |  |  | 2988 |
|  | &nbsp;&nbsp;PAC GAS & ELEC CO FIXED 3.15% DUE 01-01-2026 |  |  | 942 |
|  | &nbsp;&nbsp;PNC BANK NA FLTG 01-15-2027 |  |  | 3404 |
|  | &nbsp;&nbsp;PVTPL AGL CLO 14 LTD SR 21-14A CL AR FRN 12-02-2034 |  |  | 1700 |
|  | &nbsp;&nbsp;PVTPL APIDOS CLO LTD SR 12-11A CL AR4 FRN 04-17-2034 |  |  | 1300 |
|  | &nbsp;&nbsp;PVTPL APIDOS CLO XXXV LLC SER 21-35A CL A FLTG RT DUE 04-20-2034 |  |  | 250 |
|  | &nbsp;&nbsp;PVTPL ARES XXVII CLO LTD SR 13 2A CL A-R3 FLTG 10-28-2034 |  |  | 2001 |
|  | &nbsp;&nbsp;PVTPL ARI FLEET LEASE TR 2023-A 5.41% 02-17-2032 |  |  | 162 |
|  | &nbsp;&nbsp;PVTPL ATHENE GLOBAL FUNDING FLTG 09-18-2028 |  |  | 697 |
|  | &nbsp;&nbsp;PVTPL ATHENE GLOBAL FUNDING FLTG RT 07-16-2026 |  |  | 8212 |
|  | &nbsp;&nbsp;PVTPL ATHENE GLOBAL FUNDING FLTG RT 01-07-2027 |  |  | 2004 |
|  | &nbsp;&nbsp;PVTPL ATLANTIC AVE 2024-3 LTD SR 24-3A CL A FLTG 01-20-2035 |  |  | 2000 |
|  | &nbsp;&nbsp;PVTPL AVIATION CAPITAL GROUP 1.95% DUE 09-20-2026 BEO |  |  | 3345 |
|  | &nbsp;&nbsp;PVTPL BAIN CAPITAL CREDIT CLO LIMITED SR 20-2A CL ARR FLTG RT 07-19-2034 |  |  | 3101 |
|  | &nbsp;&nbsp;PVTPL BAIN CAPITAL CREDIT CLO LTD SR 21-3A AR FLTG RT 07-24-2034 |  |  | 250 |
|  | &nbsp;&nbsp;PVTPL BANQUE FED CRED MUTUEL FLTG RT 01-23-2027 |  |  | 1408 |
|  | &nbsp;&nbsp;PVTPL BLUEMOUNTAIN CLO LTD SR 22-34A CL AR FLTG RT 04-20-2035 |  |  | 300 |
|  | &nbsp;&nbsp;PVTPL BMW US CAP LLC FLTG 08-11-2027 |  |  | 2005 |
|  | &nbsp;&nbsp;PVTPL BMW US CAPITAL LLC FLTG RT 144A 03-19-2027 |  |  | 402 |
|  | &nbsp;&nbsp;PVTPL CITIZENS AUTO RECEIVABLES TR TR 2024-2 SER 24-2 CL A3 5.33% 08-15-2028 |  |  | 333 |
|  | &nbsp;&nbsp;PVTPL CMO COLT 2021-4 MTG LN TR MTG PASSTHRU CTF CL A-1 10-25-2066 |  |  | 1590 |
|  | &nbsp;&nbsp;PVTPL CQS US CLO LTD SER 21-1A CL AR FLTG 01-20-2035 |  |  | 2002 |
|  | &nbsp;&nbsp;PVTPL CREDIT AGRICOLE S A LONDON BRH 1.247% 01-26-2027 |  |  | 998 |
|  | &nbsp;&nbsp;PVTPL GPMT 2021-FL3 LTD/GPMT 2021-FL3 LLC SR SECD NT CL A FLTG 07-16-2035 |  |  | 132 |
|  | &nbsp;&nbsp;PVTPL GUGGENHEIM CLO LTD SR 22-2A CL A1R FLTG RT 01-15-2035 |  |  | 1000 |
|  | &nbsp;&nbsp;PVTPL JACKSON NATL LIFE GLOBAL 4.9% 01-13-2027 |  |  | 1210 |
|  | &nbsp;&nbsp;PVTPL KKR FINANCIAL CLO LTD SR 42A CL ARFLTG RT 07-20-2034 |  |  | 2000 |
|  | &nbsp;&nbsp;PVTPL KOMMUNALBANKEN AS FLTG RT 06-25-2027 |  |  | 8006 |
|  | &nbsp;&nbsp;PVTPL LCM 31 LTD SR SECD NT CL A-R FLTG 07-20-2034 |  |  | 1101 |
|  | &nbsp;&nbsp;PVTPL MADISON PK FDG SER 21-49A CL AR FLTG 10-19-2034 |  |  | 998 |
|  | &nbsp;&nbsp;PVTPL MF1 MULTIFAMILY HOUSING MORTGAGE CO SER 21-FL7 CL A FLTG RT DUE 10-18-2036 |  |  | 1000 |
|  | &nbsp;&nbsp;PVTPL NAVIENT PRIVATE ED REFI LN TR 2021-G CL A 1.58% DUE 04-15-2070 BEO |  |  | 1083 |
|  | &nbsp;&nbsp;PVTPL NAVIENT PRIVATE ED REFI LN TR SRS 20-HA CL A 1.31% DUE 01-15-2069 |  |  | 445 |
|  | &nbsp;&nbsp;PVTPL NAVIENT STUDENT LN TR 2014-1 SR 22-A CL A 2.23% 07-15-2070 |  |  | 824 |
|  | &nbsp;&nbsp;PVTPL NELNET STUDENT LN TR FLTG RT SER 19-2A CL A 06-27-2067 BEO |  |  | 959 |
|  | &nbsp;&nbsp;PVTPL NISSAN MTR ACCEP CO LLC NT 1.85% 09-16-2026 |  |  | 878 |
|  | &nbsp;&nbsp;PVTPL NTT FIN CORP 03/04/2026 1.162% DUE04-03-2026/03-03-2021 BEO |  |  | 3970 |
|  | &nbsp;&nbsp;PVTPL OCEAN TRAILS CLO SR 21-11A CL AR FRN 07-20-2034 |  |  | 1098 |
|  | &nbsp;&nbsp;PVTPL OCTAGON LTD SR 22-1A CL A1R FLTG RT 07-21-2035 |  |  | 2200 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Corporate debt - continued** |  |  |  |
|  | &nbsp;&nbsp;PVTPL PARALLEL LTD SR 21-1A CL AR FLTG RT 07-15-2034 |  |  | 2598 |
|  | &nbsp;&nbsp;PVTPL POST CLO LTD 21-1A AR FLTG RATE DUE 10-15-2034 BEO |  |  | 1999 |
|  | &nbsp;&nbsp;PVTPL REGATTA XVI FUNDING LTD SR 19-2A CL A1R FLTG RT 01-15-2033 |  |  | 3375 |
|  | &nbsp;&nbsp;PVTPL RELIANCE STD LIFE GLOBAL FDG II 1.512% 09-28-2026 |  |  | 5137 |
|  | &nbsp;&nbsp;PVTPL RGA GLOBAL FDG 2.0% 11-30-2026 |  |  | 491 |
|  | &nbsp;&nbsp;PVTPL ROCKFORD TOWER CLO LTD SR22-1A CL A1R VAR RT 07-20-2035 |  |  | 500 |
|  | &nbsp;&nbsp;PVTPL ROMARK CLO LTD 2021-4 SR 21-4A CL A1R FLTG 07-10-2034 |  |  | 2000 |
|  | &nbsp;&nbsp;PVTPL SBA TOWER TR 4.831% 10-15-2029 |  |  | 1410 |
|  | &nbsp;&nbsp;PVTPL SHACKLETON CLO LTD SR 19-14A CL A1R FLTG RT 07-20-2034 |  |  | 1701 |
|  | &nbsp;&nbsp;PVTPL SILVER ROCK CLO LTD 2021-2 SR 21-2A L AR FTG RT 01-20-2035 |  |  | 999 |
|  | &nbsp;&nbsp;PVTPL SYMPHONY CLO LTD SR 20-22A CL A1ARFLTG RT 04-18-2033 |  |  | 839 |
|  | &nbsp;&nbsp;PVTPL SYMPHONY CLO LTD SR 21-25A CL AR FLTG RT 04-19-2034 |  |  | 500 |
|  | &nbsp;&nbsp;PVTPL THAYER PK CLO LTD SER 17-1A CL A1RR FLTG 04-20-2034 |  |  | 1298 |
|  | &nbsp;&nbsp;PVTPL TOWD POINT MORTGAGE TRUST SER 21-1 CL A1 VAR 11-25-2061 |  |  | 1236 |
|  | &nbsp;&nbsp;PVTPL TOYOTA LEASE OWNER TRUST SR 24-B CL A2B FLTG RT 02-22-2027 |  |  | 182 |
|  | &nbsp;&nbsp;PVTPL TRINITAS CLO LTD SER 17-7A CL A1R2 FLTG RT 01-25-2035 |  |  | 999 |
|  | &nbsp;&nbsp;PVTPL TTRALEE CLO LTD SER 18-5A CL A1RR FLTG 10-20-2034 |  |  | 899 |
|  | &nbsp;&nbsp;PVTPL UBS GROUP AG 1.305% 02-02-2027 |  |  | 6879 |
|  | &nbsp;&nbsp;PVTPL UNITED OVERSEAS BANK LTD FLTG 04-02-2028 |  |  | 3707 |
|  | &nbsp;&nbsp;PVTPL USAA AUTO OWNER TRUST SER 23-A CL A3 5.58% DUE 05-15-2028 |  |  | 436 |
|  | &nbsp;&nbsp;PVTPL VICI PROPERTIES INC 4.5% 09-01-2026 |  |  | 1001 |
|  | &nbsp;&nbsp;PVTPL VOLKSWAGEN GROUP AMER FIN LLC 5.7% 09-12-2026 |  |  | 404 |
|  | &nbsp;&nbsp;PVTPL VOYA CLO LTD SR 19-2A CL AR FLTG 07-20-2032 |  |  | 831 |
|  | &nbsp;&nbsp;PVTPL WHETSTONE PK CLO LTD/WHETSTONE PK CLO SR 21-1A CLS A1R FLTG 01-20-2035 |  |  | 1499 |
|  | &nbsp;&nbsp;PVTPL WIND RIV 2021-2 CLO LTD/WIND RIV 2021- SR 21-2A CL A1R VAR RT 07-20-2034 |  |  | 1200 |
|  | &nbsp;&nbsp;ROCKFORD TOWER CLO FLTG RT 5.32886% DUE 07-20-2034 |  |  | 4098 |
|  | &nbsp;&nbsp;SARANAC CLO VI LTD / SARANAC CLO VI 5.12481% 08-13-2031 |  |  | 199 |
|  | &nbsp;&nbsp;SOFI PROFESSIONAL LN PROGRAM 2020-C POSTGRADUATE LN AST BKD NT 1.95% 02-15-2046 |  |  | 623 |
|  | &nbsp;&nbsp;SOUTHERN CALIF EDISON CO 4.9% 06-01-2026 |  |  | 4106 |
|  | &nbsp;&nbsp;VOLKSWAGEN GROUP AMER FIN LLC FLTG 03-20-2026 |  |  | 3303 |
|  | &nbsp;&nbsp;WORLD OMNI FLTG RT 4.13735% DUE 02-16-2027 |  |  | 133 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Corporate debt |  |  | 227462 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity**<br>**date &**<br>**range of**<br>**interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Government debt** |  |  |  |
|  | &nbsp;&nbsp;FANNIE MAE SR 24-103 CL FC FLTG RT 01-25-2055 |  |  | 816 |
|  | &nbsp;&nbsp;FANNIE MAE SR 24-90 CL FB FLTG RT 11-25-2053 |  |  | 2320 |
|  | &nbsp;&nbsp;FANNIE MAE SR 25-18 CL FM FLTG RT 09-25-2054 |  |  | 973 |
|  | &nbsp;&nbsp;FANNIE MAE SR 25-95 CL F FLTG RT 12-25-2053 |  |  | 1574 |
|  | &nbsp;&nbsp;FANNIE MAE TR SR 24-95 CL KF FLTG 12-25-2054 |  |  | 1213 |
|  | &nbsp;&nbsp;FEDERAL HOME LN MTG CORP SER 005557 CL FM 4.76721% 07-25-2055 |  |  | 1369 |
|  | &nbsp;&nbsp;FEDERAL HOME LN MTG CORP SER 005584 CL DF 4.56721% 10-25-2055 |  |  | 483 |
|  | &nbsp;&nbsp;FEDERAL HOME LN MTG CORP SER 5442 CL FB FLTG 08-25-2054 |  |  | 2114 |
|  | &nbsp;&nbsp;FEDERAL HOME LN MTG CORP SER 5565 CL FA FLTG RT 08-25-2055 |  |  | 1139 |
|  | &nbsp;&nbsp;FEDERAL HOME LN MTG CORP SER 5567 CL FB FLTG RT 08-25-2055 |  |  | 180 |
|  | &nbsp;&nbsp;FEDERAL HOME LN MTG CORP SR 5560 CL FB FLTG RT 06-25-2055 |  |  | 1246 |
|  | &nbsp;&nbsp;FEDERAL HOME LN MTG CORP SR 5601 CL F FLTG RT 11-25-2055 |  |  | 496 |
|  | &nbsp;&nbsp;FEDERAL NATIONAL MORTGAGE ASSOC REMIC TR2024-100 CL-FA VAR 4.76721% 06-25-2054 |  |  | 1363 |
|  | &nbsp;&nbsp;FHLMC SR 5480 CL FG FLTG RT 12-25-2054 |  |  | 681 |
|  | &nbsp;&nbsp;FHLMC SR 5565 CL FB FLTG 08-25-2055 |  |  | 988 |
|  | &nbsp;&nbsp;FNMA FLTG RT 11-05-2027 |  |  | 6010 |
|  | &nbsp;&nbsp;FNMA REMIC TR 2024-101 CL-FB VAR 4.76721% 01-25-2055 |  |  | 1756 |
|  | &nbsp;&nbsp;FNMA REMIC TR 2024-104 CL-FA VAR 4.71721% 01-25-2055 |  |  | 820 |
|  | &nbsp;&nbsp;FNMA REMIC TR 2025-35 CL-FB VAR 4.66721%05-25-2055 |  |  | 583 |
|  | &nbsp;&nbsp;FNMA SR 25-35 CL FM FLTG RT 05-25-2055 |  |  | 377 |
|  | &nbsp;&nbsp;FNMA SR 25-54 CL FM FLTG RT 07-25-2055 |  |  | 824 |
|  | &nbsp;&nbsp;FREDDIE MAC MULTICLASS SR 5410 CL FB FLTG RT 05-25-2054 |  |  | 1233 |
|  | &nbsp;&nbsp;FREDDIE MAC SER 5508 CL DF FLTG RT 02-25-2055 |  |  | 1475 |
|  | &nbsp;&nbsp;FREDDIE MAC SER 5508 CL FC FLTG 02-25-2055 |  |  | 746 |
|  | &nbsp;&nbsp;FREDDIE MAC SR -5544 CL F FLTG RT 06-25-2055 |  |  | 1340 |
|  | &nbsp;&nbsp;FREDDIE MAC SR 5484 CL FA FLTG RT 12-25-2054 |  |  | 1455 |
|  | &nbsp;&nbsp;FREDDIE MAC SR 5493 CL FK FLTG 01-25-2055 |  |  | 788 |
|  | &nbsp;&nbsp;FREDDIE MAC SR 5500 CL UF FLTG 11-25-2054 |  |  | 1294 |
|  | &nbsp;&nbsp;FREDDIE MAC SR 5508 CL AF FLTG RT 02-25-2055 |  |  | 2466 |
|  | &nbsp;&nbsp;FREDDIE MAC SR 5513 CL MF FLTG RT 11-25-2054 |  |  | 3013 |
|  | &nbsp;&nbsp;GNMA 2016-H17 MTG PASS THRU CTF CL MX FC08-20-2066 |  |  | 159 |
|  | &nbsp;&nbsp;GNMA 2016-H20 REMIC PASSTHRU CTF CL MX-PT 09-20-2066 |  |  | 371 |
|  | &nbsp;&nbsp;GNMA REMIC PASSTHRU SER 2016-H11 CLS F 05-20-2066 |  |  | 29 |
|  | &nbsp;&nbsp;GNMA SR 23-H22 CL FB FLTG RT 09-20-2073 |  |  | 2858 |
|  | &nbsp;&nbsp;GNMA SR 25-98 CL GF FLTG RT 06-20-2055 |  |  | 885 |
|  | &nbsp;&nbsp;GNMA SR 25-H20 CL FA FLTG RT 09-20-2075 |  |  | 251 |
|  | &nbsp;&nbsp;GNMA SR 25-H22 CL F FLTG RT 10-20-2075 |  |  | 250 |
|  | &nbsp;&nbsp;UNITED STATES TREASURY BILLS 0% 05-07-2026 |  |  | 70 |
|  | &nbsp;&nbsp;UNITED STATES OF AMER TREAS NOTES 4.0% 02-28-2030 |  |  | 58275 |
|  | &nbsp;&nbsp;UNITED STATES TREAS NTS DTD 04/30/2025 3.875% 04-30-2030 |  |  | 3833 |
|  | &nbsp;&nbsp;UNITED STATES TREAS NTS DTD 07/31/2025 3.875% 07-31-2030 |  |  | 76223 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Government debt |  |  | 184339 |
|  | **Private 40-Act mutual funds** |  |  |  |
|  | &nbsp;&nbsp;PIMCO SHORT-TERM FLOATING NAV PORTFOLIO II |  |  | 398213 |

---

#### Abbott Laboratories Stock Retirement Plan

#### EIN: 36-0698440, Plan Number: 334

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) - Continued

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | <br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity date &**<br>**range of interest** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  |  | Interest rates 3.25% to 9.75% |  |  |
| \* | **Loans to participants** | Various maturities through 2047 |  | 107491 |
|  |  |  |  | $17767239 |

---

\* Represents a party-in-interest transaction.

\*\* Cost information omitted as all investments are fully participant directed.

#### FINANCIAL STATEMENTS AND

#### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

#### ABBOTT LABORATORIES STOCK RETIREMENT PLAN (PUERTO RICO)
**DECEMBER 31, 2025 and 2024**

#### C O N T E N T S

---

| | |
|:---|:---|
|  | **Page** |
| [REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM](#Report2) | 3 |
| FINANCIAL STATEMENTS |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS](#NetAssets2) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS](#ChangeinNetAssets2) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[NOTES TO FINANCIAL STATEMENTS](#NOTEADESCRIPTIONOFTHEPLAN2) | 6 |
| [SUPPLEMENTAL SCHEDULE](#SUPPLEMENTALSCHEDULE2_17620) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)](#ScheduleH2) | 13 |

---

#### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Plan Administrator and Plan Participants

Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### Opinion on the financial statements
We have audited the accompanying statements of net assets available for benefits of Abbott Laboratories Stock Retirement Plan (Puerto Rico) (the "Plan") as of December 31, 2025 and 2024, the related statement of changes in net assets available for benefits for the year ended December 31, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2025 and 2024, and the changes in net assets available for benefits for the year ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.

#### Basis for opinion
These financial statements are the responsibility of the Plan's management. Our responsibility is to express an opinion on the Plan's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

#### Supplemental information
The schedule of assets (held at end of year) as of December 31, 2025 ("supplemental information") has been subjected to audit procedures performed in conjunction with the audit of the Plan's financial statements. The supplemental information is the responsibility of the Plan's management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor's Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.

/s/ GRANT THORNTON LLP

We have served as the Plan's auditor since 2014.

Chicago, Illinois

June 18, 2026

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS

#### December 31, 2025 and 2024

#### (Dollars in thousands)

------

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Assets |  |  |
| &nbsp;&nbsp;Cash | $30 | $27 |
| &nbsp;&nbsp;Investments, at fair value | 264892 | 237222 |
| &nbsp;&nbsp;Notes receivable from participants | 6124 | 5803 |
| &nbsp;&nbsp;Due from brokers | 6 | 22 |
| &nbsp;&nbsp;Accrued interest income | 40 | 225 |
| **NET ASSETS AVAILABLE FOR BENEFITS** | $**271092** | $**243299** |

---

The accompanying notes are an integral part of these statements.

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS

#### Year ended December 31, 2025

#### (Dollars in thousands)

------

---

| | |
|:---|:---|
| Additions |  |
| &nbsp;&nbsp;Contributions |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employer | $2527 |
| &nbsp;&nbsp;&nbsp;&nbsp;Participant | 5179 |
| &nbsp;&nbsp;&nbsp;&nbsp;Rollovers | 110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total contributions | 7816 |
| &nbsp;&nbsp;Investment income |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net appreciation in fair value of investments | 34461 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and dividends | 6246 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 40707 |
| &nbsp;&nbsp;Interest income on notes receivable from participants | 429 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net additions | 48952 |
| Deductions |  |
| &nbsp;&nbsp;Benefits paid to participants | 21133 |
| &nbsp;&nbsp;Other expenses | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deductions | 21159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**NET INCREASE** | 27793 |
| Net assets available for benefits |  |
| &nbsp;&nbsp;Beginning of year | 243299 |
| &nbsp;&nbsp;End of year | $271092 |

---

The accompanying notes are an integral part of this statement.

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### NOTES TO FINANCIAL STATEMENTS

#### December 31, 2025 and 2024

------

#### NOTE A - DESCRIPTION OF THE PLAN
The following description of the Abbott Laboratories Stock Retirement Plan (Puerto Rico) (the "Plan") provides only general information. Participants should refer to the Plan document for a more complete description of the Plan's provisions.

#### General
The Plan was established January 1, 2013 in conjunction with Abbott Laboratories ("Abbott") separating into two publicly traded companies – Abbott and AbbVie Inc. ("AbbVie"). The Plan covers employees of Abbott's selected subsidiaries and affiliates in Puerto Rico (the "Company").

The Plan is a profit-sharing plan containing a cash or deferred arrangement intended to qualify for favorable tax treatment under sections 1081.01 (a) and (d) of the Puerto Rico Internal Revenue Code of 2011, as amended. In addition, the Plan provides an arrangement by which employees may invest in Abbott shares. Employees of the Company may, after meeting certain employment requirements, voluntarily participate in the Plan. Beginning March 2017, newly hired employees in certain specified Abbott divisions and business units became eligible to participate in the Plan under a different structure ("Abbott Green" employees).

The Plan's sponsor is Abbott Healthcare (Puerto Rico) S.a.r.l. Alight Solutions serves as the recordkeeper of the Plan. The Northern Trust Company ("Custodian") and Banco Popular de Puerto Rico ("Trustee") serve as the Plan's custodian and trustee, respectively. The Plan is subject to the Employee Retirement Income Security Act of 1974, as amended ("ERISA").

#### Contributions and Vesting
Contributions to the Plan are paid to a trust administered by the Trustee. An investment committee (the "Committee") may direct the Trustee to establish investment options of the Committee's choosing.

Employees are eligible to commence participation in the Plan on any entry date following their date of hire. Eligible employees electing to participate may contribute from 2% (or 1%, for Abbott Green participants) to 25% of their eligible earnings, subject to certain limitations. Participants may choose to make their contributions from either pretax earnings or after-tax earnings, or both. Participants who have attained age 50 before the end of the Plan year and who are making the maximum pretax contribution are eligible to make catch-up contributions. Participants may elect to invest their contributions in any or all of the investment options, except for investment options closed to new contributions.

Employer matching contributions to the Plan are made each payroll period based on the participating employees' eligible earnings. Excluding the Abbott Green participants, the employer contribution for the year ended December 31, 2025 was 5% of the participant's eligible earnings if the participant elected to contribute at least 2% of eligible earnings to the Plan. Effective with the first pay period ending after March 1, 2017, employer matching contributions for Abbott Green participants are made at the rate of 100% up to a 3% deferral of eligible earnings. Employer contributions are invested each pay period according to the participant's investment elections.

In connection with the January 1, 2013 separation of Abbott into two publicly traded companies, Abbott shareholders received as a tax-free distribution one share of AbbVie stock for every share of Abbott held as of the close of business on December 12, 2012, the record date for the distribution. Plan participants may continue to hold the AbbVie stock they received from the distribution; however, they may not make new contributions or transfer existing contributions or earnings to purchase AbbVie stock in the Plan. AbbVie dividends are invested in the Plan's default investment option.

Participants may direct the Trustee to sell all or a portion of the Abbott and AbbVie common shares held in their accounts and reinvest the proceeds in any of the other investment options available to the participants.

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE A - DESCRIPTION OF THE PLAN - Continued

#### Contributions and Vesting - Continued
Participants are at all times fully vested in their own contributions and earnings thereon. Vesting in employer contributions and earnings thereon is based on the following vesting schedule:

---

| | |
|:---|:---|
| <br>**Service** | **Vesting**<br>**percentage** |
| Less than two years | 0% |
| Two years or more | 100% |

---

A participant becomes 100% vested in his or her employer contributions if, while employed by the Company, he or she dies or attains age 65.

Abbott Green participants who first became participants prior to January 1, 2018 are also fully vested in matching contributions upon qualifying disability.

Non-vested portions of employer contributions and earnings thereon are forfeited as of an employee's termination date. Through December 31, 2024, forfeitures were used to (1) restore any forfeitures of participants who returned to service with the Company within a given period of time, (2) pay Plan expenses as deemed appropriate by the administrator, and (3) reduce future employer contributions if terminated participants do not return to service within the given period of time. Effective January 1, 2025, forfeitures are used to (1) restore any forfeitures of participants who returned to service with the Company within a given period of time, and (2) reduce future employer contributions if terminated participants do not return to service within the given period of time.

In 2025, approximately $35,600 of forfeitures were used to reduce employer contributions. Forfeitures totaling approximately $107,900 and $109,300 were available at the end of 2025 and 2024, respectively.

#### Distributions and In-Service Withdrawals
Following retirement, termination or death, participants or their beneficiaries may elect to receive a distribution in installments, a single lump sum or a partial lump sum. Participants may elect a direct rollover of their accounts. Interest, dividends and other earnings will continue to accrue on any deferred amounts prior to distribution.

Prior to termination, participants are permitted to withdraw their after-tax contributions (after-tax contributions made on or after January 8, 2016 may be withdrawn from the Plan only after being held for two or more years) and rollover contributions (including merged-in plan rollover accounts) and, after age 59 ½, may also withdraw pretax contributions. Distributions are made in cash or, to the extent contained in the participant's account, a participant may elect distribution of Abbott and AbbVie common shares, and in each case, are subject to certain limitations.

#### Notes Receivable from Participants
Participants may convert their vested account balances into one or two loans to themselves. The borrowing may not exceed the lesser of the current market value of the assets allocated to their vested accounts or 50% of all of their Plan accounts up to $50,000, subject to Puerto Rico Internal Revenue Code limitations and restrictions. Participants pay interest on such borrowings at the prime rate in effect at the time the participant loan is made. Loans must be repaid within five years unless the loan is used for the purchase of the primary residence of the employee, in which case the repayment period can be extended to a period of fifteen years. Repayment is generally made through periodic payroll deductions or by sending in a payment, but a loan may be repaid in a lump sum at any time. Post-termination loan repayments are permitted. For employees whose account is distributed during the repayment period, the balance of the outstanding loan is netted from their Plan distribution.

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

#### Basis of Accounting
The financial statements have been prepared using the accrual basis of accounting.

#### Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and changes therein, and disclosure of contingent assets and liabilities. Actual results may differ from those estimates.

#### Investment Valuation
The Plan uses the following methods and significant assumptions to estimate the fair value of investments:

Common stock and mutual funds - Valued at the published market price per share or unit multiplied by the number of shares or units held.

Collective trust funds - Valued at the net asset value ("NAV") provided by the administrator of the fund. The NAV is used as a practical expedient to estimate fair value. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding.

The following tables summarize the basis used to measure investments at fair value at December 31, 2025 and 2024 (dollars in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | |
| **2025** | **Quoted**<br>**Prices in**<br>**Active**<br>**Markets** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs** | <br>**Significant**<br>**Unobservable**<br>**Inputs** | <br><br>**Measured at**<br>**NAV** | <br><br>**Total** |
| Common stock | $106951 | $— | $— | $— | $106951 |
| Mutual funds | 52452 |  |  |  | 52452 |
| Collective trust funds |  |  |  | 105489 | 105489 |
| &nbsp;&nbsp;Total investments, at fair value | $159403 | $— | $— | $105489 | $264892 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | **Basis of Fair Value Measurement** | |
| **2024** | **Quoted**<br>**Prices in**<br>**Active**<br>**Markets** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs** | <br>**Significant**<br>**Unobservable**<br>**Inputs** | <br>**Measured at**<br>**NAV** | <br>**Total** |
| Common stock | $96512 | $— | $— | $— | $96512 |
| Mutual funds | 48681 |  |  |  | 48681 |
| Collective trust funds |  |  |  | 92029 | 92029 |
| &nbsp;&nbsp;Total investments, at fair value | $145193 | $— | $— | $92029 | $237222 |

---

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
***Investment Valuation – Continued***

Participants are permitted to make redemptions from the Plan's investment options on a daily basis, however, certain investments valued at NAV as a practical expedient have redemption requirements and in some cases restrictions for a Plan level redemption. The following tables provide the redemption requirements and restrictions, if any, for those investments as of December 31, 2025 and 2024 (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** |
|  | **Fair value**<br>**(NAV)** | **Redemption**<br>**frequency** | **Redemption**<br>**notice period** | &nbsp;&nbsp;&nbsp;&nbsp;<br>**Restrictions** |
| Funds filing as direct filing entity: |  |  |  |  |
| &nbsp;&nbsp;Collective trusts | $105489 | Daily | 0 - 5 days |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2024** | **2024** | **2024** | **2024** |
|  | **Fair value**<br>**(NAV)** | **Redemption**<br>**frequency** | **Redemption**<br>**notice period** | <br>**Restrictions** |
| Funds filing as direct filing entity: |  |  |  |  |
| &nbsp;&nbsp;Collective trusts | $92029 | Daily | 0 - 5 days |  |

---

#### Notes Receivable from Participants
Notes receivable from participants are measured at their unpaid balance plus any accrued but unpaid interest. Delinquent loans are reclassified as distributions based upon the terms of the Plan.

#### Income Recognition
Purchases and sales of securities are recorded on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. Net realized and unrealized appreciation/depreciation is recorded in the accompanying statement of changes in net assets available for benefits as net appreciation in fair value of investments.

#### Contributions
Contributions from Plan participants and the matching contributions from the employer are recorded in the year in which the employee contributions are withheld from compensation.

#### Administrative Expenses
Participants are charged transaction fees for loan processing, which are included in other expenses and commissions on purchases and sales of Abbott shares and sales of AbbVie shares, which are included in net appreciation in fair value of investments. Investment fees for mutual funds and collective trusts are charged against the net assets of the respective fund and are also included in net appreciation in fair value of investments. The Company pays other recordkeeping and administration fees, where applicable. Expenses paid by the Company are excluded from these financial statements.

#### Payment of Benefits
Benefits are recorded when paid.

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE C - INVESTMENTS
Distributions of Abbott common shares and conversions of participants' common share account balances to participant loans or other investment options are recorded at fair market value.

A summary of Abbott common share data as of December 31, 2025 and 2024 is presented below:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Abbott common shares, 529,424 and 553,452 shares, respectively (dollars in thousands) | $66331 | $62601 |
| Market price per share | $125.29 | $113.11 |

---

#### NOTE D - RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS
The Plan holds units of collective trust funds managed by the Custodian. A significant portion of the Plan's assets is invested in Abbott common shares. These transactions qualify as party-in-interest transactions; however, they are exempt from the prohibited transaction rules under ERISA. During 2025, the Plan received $1,282,300 in common stock dividends from Abbott.

Participants pay fees to the recordkeeper for loan transaction processing and for commissions on purchases and sales of Abbott shares and sales of AbbVie stock. These transactions qualify as permitted party-in-interest transactions.

#### NOTE E - PLAN TERMINATION
The Plan may be terminated at any time by Abbott upon written notice to the Trustee and Committee. All participants' account balances would become fully vested upon Plan termination. Upon termination of the Plan, distributions of each participant's share in the trust, as determined by the terms of the Plan, would be made to each participant. At the present time, Abbott has no intention of terminating the Plan.

#### NOTE F - TAX STATUS
The Plan received letters dated April 19, 2016 and December 2, 2019 from the Department of the Treasury of the Commonwealth of Puerto Rico that the Plan, as written, qualifies under Section 1081.01(a) of the Puerto Rico Internal Revenue Code of 2011, as amended and, consequently, its enabling trust is exempt from local income tax. The Plan has been amended since receiving the letters. The Plan administrator believes that the Plan is designed and is currently being operated, in all material respects, in accordance with the applicable Puerto Rico Internal Revenue Code.

Accounting principles generally accepted in the United States of America require Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the organization has taken an uncertain position that more likely than not would not be sustained upon examination by the applicable taxing authorities. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2025 and 2024, there are no uncertain positions taken or expected to be taken that would require recognition of a liability or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits in progress.

#### NOTE G - RISKS AND UNCERTAINTIES
In general, the investments provided by the Plan are exposed to various risks, such as interest rate, credit and overall market volatility risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participant accounts and the amounts reported in the statements of net assets available for benefits.

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### NOTES TO FINANCIAL STATEMENTS - CONTINUED

#### December 31, 2025 and 2024

------

#### NOTE H – SUBSEQUENT EVENTS
Management of the Plan has evaluated subsequent events from December 31, 2025 through the date these financial statements were issued. Other than described below, management of the Plan is not aware of any subsequent events that require recognition or additional disclosure in these financial statements.

The following changes took effect on January 1, 2026:

Fidelity Investments replaced Alight Solutions as the recordkeeper of the Plan. For the Abbott and AbbVie common stock investment options only, Fidelity Management Trust Company replaced The Northern Trust Company as custodian.

A participant who has a balance in the AbbVie common stock investment option will have dividends invested across the participant's investment elections on file for future contributions.

Non-vested portions of employer contributions and earnings thereon are forfeited as of the date the participating employee receives a distribution or, if later, the end of the plan year in which the participating employee has been separated from Abbott for a period of five years.

SUPPLEMENTAL SCHEDULE

#### Abbott Laboratories Stock Retirement Plan (Puerto Rico)

#### EIN: 98-1051267, Plan Number: 002

#### SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

#### December 31, 2025

#### (Dollars in thousands)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**(a)** | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(b) Identity of issue, borrower, lessor, or similar party** | **(c) Description**<br>**of investment**<br>**including**<br>**maturity date &**<br>**range of interest** | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(d) Cost** <sup>\*\*</sup> | &nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>**(e) Current**<br>**value** |
|  | **Common stock - employer securities** |  |  |  |
| \* | &nbsp;&nbsp;Abbott Laboratories, common shares |  |  | $66331 |
|  | **Common stock** |  |  |  |
|  | &nbsp;&nbsp;AbbVie Inc., common stock |  |  | 40620 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Common stock |  |  | 106951 |
|  | **Mutual funds** |  |  |  |
|  | &nbsp;&nbsp;American Funds EUPAC Fund |  |  | 7435 |
|  | &nbsp;&nbsp;American Funds The Growth Fund of America Fund |  |  | 21768 |
|  | &nbsp;&nbsp;American Funds Washington Mutual Investors Fund |  |  | 5489 |
|  | &nbsp;&nbsp;PIMCO All Asset Fund |  |  | 2106 |
|  | &nbsp;&nbsp;PIMCO Short Asset Investment Fund |  |  | 12015 |
|  | &nbsp;&nbsp;Vanguard Mid-Cap Value Index Fund Admiral |  |  | 3639 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Mutual funds |  |  | 52452 |
|  | **Collective trust funds** |  |  |  |
|  | &nbsp;&nbsp;Blackrock International Opportunities Fund |  |  | 2079 |
|  | &nbsp;&nbsp;GW&K Small-Mid Cap Core Equity Fund |  |  | 3112 |
| \* | &nbsp;&nbsp;Northern Trust Collective ACWI ex-U.S. Index Fund |  |  | 2086 |
| \* | &nbsp;&nbsp;Northern Trust Collective Short Term Investment Fund |  |  | 108 |
|  | &nbsp;&nbsp;PIMCO Total Return Fund |  |  | 1993 |
|  | &nbsp;&nbsp;SSGA Russell Small/Mid Cap Index Fund |  |  | 4327 |
|  | &nbsp;&nbsp;SSGA S&P 500 Index Fund |  |  | 22624 |
|  | &nbsp;&nbsp;SSGA U.S. Bond Index Fund |  |  | 1698 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2025 |  |  | 9990 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2030 |  |  | 12500 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2035 |  |  | 9338 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2040 |  |  | 9485 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2045 |  |  | 7371 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2050 |  |  | 4796 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2055 |  |  | 2980 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2060 |  |  | 1164 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2065 |  |  | 529 |
|  | &nbsp;&nbsp;SSGA Target Retirement 2070 |  |  | 2 |
|  | &nbsp;&nbsp;SSGA Target Retirement Income |  |  | 9307 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Collective trust funds |  |  | 105489 |
|  |  | Interest rates 3.25% to 8.50% | Interest rates 3.25% to 8.50% |  |
| \* | **Loans to participants** | Various maturities through 2040 | Various maturities through 2040 | 6124 |
|  |  |  |  | $271016 |

---

<sup>\*</sup> Represents a party-in-interest transaction.

<sup>\*\*</sup> Cost information omitted as all investments are fully participant directed.

#### EXHIBIT INDEX

---

| | |
|:---|:---|
| Exhibit No. | Exhibit |
| 23.1 | [Consent of Independent Registered Public Accounting Firm – Abbott Laboratories Stock Retirement Plan.](abt-20251231xex23d1.htm) |
| 23.2 | [Consent of Independent Registered Public Accounting Firm – Abbott Laboratories Stock Retirement Plan (Puerto Rico).](abt-20251231xex23d2.htm) |

---

#### SIGNATURE
*The Plan*. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM

---

| | | | |
|:---|:---|:---|:---|
| Date: | June 18, 2026 | By: | /s/ Sean J. Treacy |
|  |  |  | Sean J. Treacy |
|  |  |  | Plan Administrator |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We have issued our report dated June 18, 2026, with respect to the financial statements and supplemental information included in the Annual Report of Abbott Laboratories Stock Retirement Plan on Form 11-K for the year ended December 31, 2025. We consent to the incorporation by reference of said report in the Registration Statement of Abbott Laboratories on Form S-8 (File No. 33-26685, File No. 33-504522, File No. 33-51585, File No. 33-56897, File No. 33-65127, File No. 333-19511, File No. 333-43383, File No. 333-69579, File No. 333-93257, File No. 333-74224, File No. 333-102180, File No. 333-109253, File No. 333-124849, File No. 333-141116, File No. 333-153198, File No. 333-169888, File No. 333-204772, File No. 333-227802, and File No. 333-251335).

---

| |
|:---|
| /s/ GRANT THORNTON LLP |
| Chicago, Illinois |
| June 18, 2026 |

---

------

## Exhibit 23.2

**Exhibit 23.2**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We have issued our report dated June 18, 2026, with respect to the financial statements and supplemental information included in the Annual Report of Abbott Laboratories Stock Retirement Plan (Puerto Rico) on Form 11-K for the year ended December 31, 2025. We consent to the incorporation by reference of said report in the Registration Statement of Abbott Laboratories on Form S-8 (File No. 33-26685, File No. 33-504522, File No. 33-51585, File No. 33-56897, File No. 33-65127, File No. 333-19511, File No. 333-43383, File No. 333-69579, File No. 333-93257, File No. 333-74224, File No. 333-102180, File No. 333-109253, File No. 333-124849, File No. 333-141116, File No. 333-153198, File No. 333-169888, File No. 333-204772, File No. 333-227802, and File No. 333-251335).

---

| |
|:---|
| /s/ GRANT THORNTON LLP |
| Chicago, Illinois |
| June 18, 2026 |

---

------